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Osteoarthritis (OA) is the most common form of arthritis worldwide, and mostly affects knee 
joint. The patients with knee OA usually suffer from severe knee symptoms and may even live 
with disability. There is no approved disease-modifying treatment available for knee OA, and 
existing management may only have limited effects or even have a range of side-effects. Thus, 
developing the preventive strategies of knee OA may be an effective way in reducing the 
disease burden. Magnetic resonance imaging (MRI) is an advanced technique which can detect 
early knee osteoarthritic changes. Several studies reported the associations between modifiable 
risk factors and MRI-based biomarkers in middle-aged or older adults, but few studies 
identified the relationships in young adults, who are the ideal target population for knee OA 
prevention. Therefore, this thesis aimed to describe associations between factors in early life 
and knee structures in young adults. 
 
This thesis used data from an Australian-based cohort study. In 1985, the Australian Schools 
Health and Fitness Survey (ASHFS) was conducted to provide benchmark data on the health 
and fitness of Australian school children using a nationally representative sample. A total of 
8498 children (aged 7-15 years) participated in ASHFS with childhood measurements collected. 
During 2004-2006, the Childhood Determinants of Adult Health (CDAH) study were 
conducted as a 20-year follow-up of ASHFS. 2410 participants (aged 26-36 years) completed 
a clinic visit with adult measurements collected. During 2008-2010, the participants residing 
in metropolitan Melbourne and Sydney were invited to participated in the CDAH Knee 
Cartilage study, which is a sub-study of the CDAH study. 330 participants (aged 31-41 years) 




Chapter 3 described the associations between childhood adiposity measures and adult knee 
cartilage defects and bone marrow lesions (BMLs). Childhood adiposity measures, including 
weight, body mass index (BMI), overweight status and fat mass, were associated with the 
higher risk of adult patellar cartilage defects. Childhood overweight status was associated with 
the higher risk of adult patellar BMLs. These associations persisted after further adjusting for 
corresponding adiposity measure in adulthood. No associations identified in femorotibial 
compartment. These findings suggested adiposity in childhood may have long-term and 
independent effects on patellar structural abnormalities in young adults. 
 
Chapter 4 described the associations of adiposity measures in childhood and adulthood with 
knee cartilage thickness, volume and bone area in young adults. Childhood weight and BMI 
were negatively associated with adult patellar bone area, suggesting the long-term detrimental 
effects of childhood adiposity on adult patellar morphology. Adult weight was positively 
associated with bone area in femorotibial compartments, which may be the response to 
mechanical stress from excess adiposity. Adult waist-hip ratio (WHR) and the change of WHR 
from childhood to adulthood were negatively associated with cartilage thickness, volume, and 
bone area, suggesting central obesity during early life could be detrimental to knee cartilage 
and bone morphology in young adults. 
 
Chapter 5 described associations of body composition, physical activity and physical 
performance with knee cartilage thickness and subchondral bone area in young adults. Lean 
mass was positively associated with knee cartilage thickness and subchondral bone area, 
whereas no significant associations were found for fat mass. Physical activity, including 
walking, moderate activity, vigorous activity, and total physical activity, were not associated 
with cartilage thickness or bone area. Long jump, hand grip strength, and physical work 
xxv 
 
capacity, but not leg strength, were positively associated with cartilage thickness. All the 
physical performance measures (Long jump, hand grip strength, physical work capacity, and 
leg strength) were positively associated with subchondral bone area. The significant 
associations for physical performance were largely disappeared after further adjusting for lean 
mass, and the mediation analysis confirmed the mediating effects of lean mass. These findings 
suggest that lean mass may play an important role in maintaining knee joint health in young 
adults. 
 
Chapter 6 described the associations of glucose homeostasis and metabolic syndrome (MetS) 
measures with knee cartilage defects and cartilage volume in young adults. Most glucose 
homeostasis measures, including fasting insulin, homeostatic model assessment 2 (HOMA2)-
insulin resistance, HOMA2-beta cell function, HOMA2-insulin sensitivity, but not fasting 
glucose, were associated with tibiofemoral cartilage defects. No associations were identified 
between glucose homeostasis measures and knee cartilage volume. MetS was not associated 
with knee cartilage defects or cartilage volume. However, two MetS components (high waist 
circumference and low high-density lipoprotein cholesterol) were associated with the higher 
risk of tibiofemoral cartilage defects. These results suggested glucose homeostasis and some 
MetS components may affect early cartilage damage in young adults. 
 
In conclusion, this thesis indicates that early life factors may affect knee joint health in young 
adults. Our findings may be useful in developing preventive strategies for knee OA, though 
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1.1 Overview of knee osteoarthritis (OA) 
1.1.1 What is knee OA 
OA is a common form of arthritis, and knee is the most commonly affected joint. The hallmark 
of knee OA is the breakdown of articular cartilage; however, knee OA also involves several 
other alterations in surrounding joint structures, including subchondral bone [1]. Pain is the 
primary symptom of knee OA and is usually the reason for seeking medical support [2]. With 
the disease progression, knee OA patients may suffer from joint stiffness, dysfunction, and 
even disability [1]. 
 
The definition of knee OA was evolving in the past decades. Kellgren-Lawrence (K-L) grading 
system was the first criteria for defining knee OA [3]. The system was an ordinal 5-point 
grading system, based on the joint characters in radiographs. The criteria were then accepted 
by the World Health Organization and were widely used in epidemiological studies. The details 
of K-L grading system are presented in Table 1.1.  
 
Table 1.1 Kellgren-Lawrence grading system 
Grade Description 
0, none No changes. 
1, doubtful Doubtful narrowing of joint space, possible osteophytic lipping. 
2, minimal Definite osteophytes, little or mild narrowing of joint space. 
3, moderate Multiple osteophytes, definite narrowing of joint space, some sclerosis, 
and possible deformity of bone ends. 
4, severe Large osteophytes, marked narrowing of joint space, severe sclerosis, 
and definite deformity of bone ends. 
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Some other systems were also developed for defining knee OA. For example, the Osteoarthritis 
Research Society International (OARSI) atlas system [4] used semi-quantitative scores to 
assess joint space narrowing (JSN) and osteophytes in each knee compartment. As these 
systems were based on radiographs, the diagnosed knee OA was usually called radiographic 
knee OA. 
 
Although the definition of radiographic knee OA was well developed, there is a major 
discordance between radiographic alterations and knee symptoms. Previous studies reported 
that only 15-76% patients with knee pain met the definition of radiographic knee OA [5]. To 
account for those without definite radiographic changes, the concept of clinical knee OA was 
developed by the American College of Rheumatology (ACR) [6]. The diagnosis of clinical 
knee OA can only utilise knee symptoms and clinical signs, such as pain, crepitus and stiffness. 
This innovation largely expanded the scope of knee OA and provided a cheap and convenient 
way in knee OA diagnosis. This innovation comes particularly important and useful for 
epidemiologic studies, which usually include larger populations with less costs. 
 
The European League Against Rheumatism (EULAR) also developed the criteria for diagnosis 
of clinical knee OA [7]. The criteria suggested that 3 symptoms (persistent knee pain, limited 
morning stiffness and reduced function) and 3 clinical signs (crepitus, restricted movement and 
bony enlargement) are mostly important and useful in diagnosis. The number of positive 
symptoms and clinical signs is positively related to the probability of having radiographic knee 
OA. When a patient has all the 3 symptoms and 3 clinical signs, the probability of having 
radiographic knee OA could be 99%. Thus, the criteria suggested that thorough clinical 
assessment alone can provide a confident rule in diagnosis of knee OA. 
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1.1.2 Epidemiology and burden 
The prevalence of knee OA could be various, as the definitions of knee OA, countries of origin, 
and age and sex composition of study population are different. The Global Burden of Disease 
2010 study estimated that the global prevalence of radiographically confirmed symptomatic 
knee OA in 2010 was 3.8% [8]. OA is a major contributor to global disability. The total years 
of life lived with disability (YLDs) associated with OA were over 12 million in 2013, which 
ranked the 13th leading cause of YLDs [9]. Moreover, OA was the 4th fastest increasing cause 
of YLDs, with a 75% increase of total YLDs from 1990 to 2013 [9]. The specific amount of 
global economic cost of knee OA is unclear. However, the amount was estimated to be large 
as both direct costs (e.g. pharmacological treatments, surgery, and caregiver payment) and 
indirect costs (e.g. loss of productivity, disability compensation, and potential 
depression/anxiety) were high [10]. 
 
In Australia, OA affects over 2.2 million people (prevalence: 9.3%). In particular, the 
prevalence increased sharply from the age of 45 years [11]. The prevalence of self-reported 
poor health, severe bodily pain, and high psychological distress were twice among Australians 
over 45 years and with OA compared to those over 45 years and without OA [11]. OA cost 
Australian health system $3.5 billion in 2015-2016, representing 28% of disease expenditure 
on musculoskeletal disorders and 3% of total disease expenditure [12]. The major expenditure 
was the cost of knee replacement. Over 53,000 knee replacement procedures with a principal 
diagnosis of knee OA were performed in Australian hospitals during 2016-17, with a total cost 
of over $1.1 billion [11, 12]. With the aging of population and the increase of 
overweight/obesity rate, the incidence of knee replacement was estimated to rise by 50% by 
2030, and the total cost was estimated to be $1.6 billion [13]. 
 




Given the heavy social and economic burden of knee OA, several disease management 
guidelines were developed by professional associations, including ACR [14], OARSI [15], 
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and 
Musculoskeletal Diseases (ESCEO) [16] and American Academy of Orthopaedic Surgeons 
(AAOS) [17]. Among these guidelines, the non-pharmacologic treatments (exercise, weight 
loss and education) were consistently suggested as the foundation of knee OA management. A 
Cochrane systematic review included 54 high-quality randomised clinical trials (RCTs) and 
reported that land-based therapeutic exercise provided benefits on reducing pain, improving 
joint function, and enhancing quality of life among knee OA patients [18]. Similarly, a recent 
systematic review summarized the findings from 12 RCTs and reported that resistance training 
improved pain and physical function in knee OA patients [19]. However, due to heterogeneity 
of the studies, the optimal exercise prescription (including the recommended kinds of exercise, 
the optimal duration, intensity, and frequency) is unavailable. Moreover, the long-term 
effectiveness of exercise is unclear as the adherence and compliance may be a barrier to gain 
an approving result [20]. For the knee OA patients who are overweight or obese, weight loss 
is important. A meta-analysis summarized the findings from 9 RCTs and reported that weight 
loss induced by diet and exercise could reduce knee pain and improve joint function in 
overweight/obese knee OA patients; however, the diet-only induced weight loss did not achieve 
a significant pain relief [21], suggesting the methods of weight loss may affect the effectiveness. 
Moreover, the degree of weight loss may be also important, as a post-hoc analysis of an RCT 
reported clear dose-responses to weight loss for knee pain, joint function and quality of life, 
and suggested that at least 10% weight loss should be obtained to get an evident result [22]. 
Patient education is an approach with potential benefits and minimal risks. Disease knowledge, 
principles of management, and effects and side effects of interventions are the key messages 
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which were suggested to be delivered to patients [23]. However, the effect size from the 
education program is small [24]. 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common medications in knee 
OA management. Two recent meta-analyses assessed the efficacy and safety of the use of 
topical NSAIDs and oral NSAIDs on knee OA respectively. In the one about topical NSAIDs, 
results from 36 RCTs suggested that topical NSAIDs can reduce pain and improve function, 
without increased local or systemic adverse effects compared to placebo [25]. In the other one 
about oral NSAIDs, results from 72 RCTs suggested that the effects from oral NSAIDs peaked 
at 2 weeks on pain remission and function improvement [26] . However, the magnitude of oral 
NSAIDs effects would decrease after the peak time, and the incidence of gastrointestinal 
adverse events would increase by 38% when using the medication for 4 weeks [26] . Thus, the 
oral NSAIDs were recommended to be used with the lowest doses and the shortest duration as 
possible. The mechanism of NSAIDs use is that the suppression of cyclooxygenase enzymes 
can reduce the synthesis of prostaglandins and then have the analgesic effects. Therefore, 
NSAIDs cannot slow or halt the development or progression of knee OA. 
 
The efficacy and safety of other pharmacologic options are controversial. For example, intra-
articular corticosteroids are strongly recommended in ACR guideline, but a Cochrane 
systematic review argued that the benefits from corticosteroids were short-term and the overall 
quality of previous evidence was low [27]. Moreover, a recent high-quality RCT used intra-
articular injection of 40 mg of triamcinolone acetonide every 3 months among symptomatic 
knee OA patients with ultrasonic features of synovitis, and reported that 2 years of intra-
articular triamcinolone (compared with intra-articular saline) cannot reduce the knee pain but 
lead to a significantly greater cartilage volume loss [28]. Thus, the effectiveness of intra-
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articular corticosteroids is still unclear. There are some other pharmacologic interventions 
suggested by the guidelines, whereas the recommendations were not consistent (Table 1.2). 
 
When knee OA patients cannot get satisfied results from all the appropriate non-surgical 
treatments, surgery would be considered. Total knee replacement was associated with greater 
symptom relief than non-surgical management among patients who were eligible for surgery 
[29]. However, the knee replacement surgery may cause a range of adverse events, including 
bleeding, infection, post-surgery chronic pain. Moreover, a study using data from two large 
OA-specific cohorts (the Osteoarthritis Initiative Study and the Multicentre Osteoarthritis 
Study) reported that, due to the high cost of surgery, current practice of total knee replacement 
for knee OA has extremely limited cost-effectiveness on improving quality of life of knee OA 
patients at the group level [30]. 
 
Although there is a broad spectrum of interventions available for knee OA management, all of 
them have either small-moderate effects, adverse event risk or high cost, and none of them have 
disease-modifying effects which can stop or slow the structural progression of knee OA. 
Primary prevention of knee OA among healthy adults may be an ideal way, as it can effectively 
and efficiently relieve the disease burden. However, it is not well-developed due to little 
available evidence. Identifying the modifiable risk factors of knee osteoarthritic changes may 
be helpful in developing the preventive strategies. The details of imaging biomarkers and 
modifiable risk factors of knee OA focused in this thesis are shown in the following sections. 
 















Opioids Duloxetine Intra-articular 
hyaluronic acid 
OARSIa 1B 1A 1B 4A 4A 4A 3 2 
AAOSb S S I I NR I NR NR 
ACRc SR SR SR CR SRA CRA CR CRA 
ESCEOd SR SR WR WRA SR WR WR WR 
 
aOARSI: Level 1A- ≥75% in favour & >50% strong, Level 1B- ≥75% in favour & >50% conditional, Level 2- 60%-74% in favour, Level 3- 
41%–59% in favour, Level 4A- 60–74% against, Level 4B- ≥75% against & >50% conditional, Level 5- 75-100% against & >50% strong. 
bAAOS: Strong (S), Moderate (M), Limited (L), Inconclusive (I), Consensus (C), NR (not recommended). 
cACR: Strong Recommendation (SR), Conditional Recommendation (CR), Conditionally Recommended Against (CRA), Strongly 
Recommended Against (SRA). 
dESCEO recommendation grades: Strong recommendation (SR), Weak recommendation (WR), Weak recommendation against (WRA), Strong 
recommendation against (SRA). 
 
Source: Adapted from Cao et al. Pharmacotherapy for knee osteoarthritis: current and emerging therapies. Expert Opinion on Pharmacotherapy. 
2020. doi: 10.1080/14656566.2020.1732924 
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1.2 Knee structures measured using MRI 
1.2.1 The advantages of MRI 
Radiography was traditionally used to diagnose knee OA based on osteophytes and JSN. In the 
recent EULAR recommendations, radiography is still the first-choice imaging modality in knee 
OA clinical management [31]. Despite the high availability and low cost, radiography has 
several limitations. The main disadvantage is that radiography cannot assess most of 
osteoarthritic features. Knee OA is a disease involving the while-joint pathologic changes, the 
disease process is complex with multiple structural alterations, such as cartilage defects, BMLs 
and meniscal damage. However, radiography cannot depict the overall circumstance of disease 
as it can only indirectly assess the knee cartilage loss using the JSN. Moreover, the radiographic 
appearance of tibiofemoral joint space is heavily dependent on knee positioning and the angle 
of joint flexion, so the reproducibility of this measure is limited and the comparison between 
multiple time points may be not accurate. 
 
MRI is an advanced technique with several advantages over radiography. The major advantage 
is it can evaluate most osteoarthritic features in both articular cartilage and periarticular 
structures including subchondral bone, meniscus and ligaments. In particular, a recent meta-
analysis reported that the prevalence of MRI-based knee OA features among asymptomatic 
uninjured knees were 4-14% in adults aged <40 years [32], suggesting MRI is important in 
assessing early knee OA changes in young adults who are the ideal target in knee OA 
prevention. Moreover, as the validity and reliability of MRI measures have been approved, the 
longitudinal changes of knee structures can be accurately assessed using MRI with the 
development and progression of knee OA. Thus, MRI has been recommended as the most 
important imaging modality for knee OA research [33]. The details of the use, advantages, and 
disadvantages of radiography and MRI for knee OA are summarised in Table 1.3. 
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Table 1.3 Summary of use, advantages and disadvantages of radiography and MRI. 
Modality Use Advantages Disadvantages 
Radiography a. First line imaging modality for routine 
clinical care of osteoarthritis 
b. Assess osteophytes and joint space 
narrowing 
c. Severity classification based on Kellgren-
Lawrence grading or Osteoarthritis Research 
Society International Atlas 
 
a. Widely available 
b. Low cost 
a. Minimal radiation 
b. Unable to depict most of osteoarthritis 
features including cartilage defects, meniscal 
damage, bone marrow lesions, synovitis, 
ligamentous damage 
c. Problem with reproducibility when 
comparing multiple time points because joint 
space width can changes depending on the 
positioning of the knee joint 
d. Limited sensitivity to change 
MRI a. Most important imaging modality for 
research 
b. Evaluation of all articular and periarticular 
structures including cartilage, meniscus, 
ligaments, bone marrow lesions, subchondral 
cysts, osteophytes, synovitis, effusion 
c. Contrast enhanced MRI can accurate 
evaluate synovitis 
d. Currently limited clinical role in routine 
patient care of osteoarthritis 
a. Detailed morphologic analysis using 
semiquantitative and quantitative techniques 
b. Pre-morphologic analysis (biochemical 
composition of articular tissues) using 
compositional techniques 
c. No radiation 
a. Costly 
b. Advanced compositional techniques may 
be limited to academic institutions with 
specialised software and hardware 
c. May be contraindicated in some patients 
(e.g. cardiac pacemaker) 
 
Source: Adapted from Hayashi et al. Recent advances in research imaging of osteoarthritis with focus on MRI, ultrasound and hybrid imaging. 
Clinical and Experimental Rheumatology 2018; 36 Suppl 114(5):43-52. 
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As MRI has several advantages in assessing knee OA, some MRI-based knee structures were 
set as imaging biomarkers and have been widely used in clinical trials and observational studies 
[34]. The following sections highlighted the MRI-based pathologic changes (cartilage defects 
and BMLs) and morphological measures (cartilage volume, cartilage thickness and bone area) 
which were focused in this thesis. 
 
1.2.2 Cartilage defects 
Cartilage defects refer to the focal damage of articular cartilage, which is usually assessed using 
semi-quantitative scoring system. It is an indicator of early cartilage damage, with a prevalence 
of 24% in asymptomatic uninjured knees [32]. The predictive value of cartilage defects to knee 
pain has been examined in several studies. A nested case-control study reported that the 
baseline cartilage defects were associated with a 3-fold odd of incident knee pain over 48 
months [35]. A population-based cohort reported that baseline cartilage defects can predict a 
2-fold risk of “moderate pain” trajectory over 10.7 years (pain scored about 15 out of 45) [36]. 
Moreover, a dose-response association between number of sites having severe cartilage defects 
and severity of knee pain was found among a community-based study [37].  
 
Cartilage defects were also associated with knee structural alterations. A nested case-control 
study reported that both partial- and full-thickness cartilage defects increased the risk of 
developing new cartilage damage in middle-aged to older adults with or at high risk of knee 
OA [38]. A population-based study reported that baseline cartilage defects could predict site-
specific BMLs progression over 2.7 years and vice versa, suggesting cartilage defects and 
BMLs are interconnected [39]. Moreover, a cohort study among older adults reported that 
baseline cartilage defect grade predicted cartilage volume loss at the medial tibia, lateral tibia 
and patella over 2.9 years (β=-1.78% to -1.27% per annum per 1 grade increase) [40]. These 
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findings were consistent with the evidence which suggested a relationship between cartilage 
defects and subsequent total knee replacement surgery. Data from the Osteoarthritis Initiative 
Cohort reported that baseline cartilage defect scores assessed using either the Whole-Organ 
Magnetic Resonance Imaging Score (WORMS) system or the Boston-Leeds Osteoarthritis 
Knee Score (BLOKS) system were significantly and independently predictive of subsequent 
knee replacement (BLOKS: Hazard ratio (HR) 3.02/score, 95% confidence interval (CI) 1.07-
8.52 ; WORMS HR 2.60/score, 95% CI 1.18-5.68) [41]. Another prospective study among 
older adults using a validated classification system (Grade 0-4) reported that per 1 grade 
increase of cartilage defects was associated a 1.73 odd of knee replacement over 5 years [40]. 
 
1.2.3 Bone marrow lesions 
BMLs represent a wide variety of early lesions in subchondral bone with high signals in MRI. 
The histopathology of BMLs has not been fully understood, but it could contain remodelled 
trabeculae, bone marrow fibrosis, bone marrow necrosis [42]. BMLs are the most important 
subchondral bone abnormalities in knee OA and have been found in asymptomatic uninjured 
adults with a prevalence of 18% [32]. The relationship between BMLs and knee pain has been 
suggested in previous studies. A recent population-based study among older adults reported 
that the presence of BMLs was associated with more severe knee pain cross-sectionally and 
knee pain progression longitudinally [43]. A prospective study reported that BML size has a 
dose-responsive relationship with the severity of knee pain in older adults [44]. In particular, a 
study in young adults reported that BMLs were cross-sectionally associated with more severe 
knee pain, suggesting the clinic significance of BMLs during early life [45].  
 
BMLs are also related to knee OA structural progression. The data from Osteoarthritis Initiative 
cohort reported that presence of baseline BMLs was associated with accelerated cartilage 
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volume loss over 2 years (medial tibia: β=-2.1% per annum; lateral tibia: β=-1.9% per annum) 
[46]. Similarly, another cohort among older adults reported that baseline patellar BMLs were 
associated with larger patellar cartilage volume loss over 2.6 years (β=-2.1% per annum) [47]. 
Moreover, in older adults, baseline BMLs were related to the higher risk of progression of 
radiographic OA, which was defined by a baseline K-L grade of 2 or 3 changing to a higher 
grade by 48-month follow-up [46]. These findings were consistent with the studies suggesting 
the predictive value of BMLs to knee replacement. A longitudinal study among symptomatic 
knee OA patients reported that per 1 BML score higher (out of 4 in total) at baseline was 
associated with a 1.57-fold odd of knee replacement over 4 years [48]. A cohort study among 
radiographic knee OA patients (K-L grade ≥2) reported that the presence of baseline BMLs 
was associated with the higher risk of knee replacement over 3 years (odds ratio (OR) range 
1.5-2.4) [46]. In particular, a follow-up of knee OA patients who participated in a clinical trial 
about intra-articular injections of hyaluronic acid reported that baseline BMLs were associated 
with a 2.3-fold odd of subsequent knee replacement over 15 years, suggesting BMLs may be 
the long-term risk of following  knee replacement surgery [49]. 
 
1.2.4 Cartilage volume, cartilage thickness and bone area 
Cartilage volume loss is the most representative hallmark of knee OA. It was previously 
indicated by JSN in radiography and now can be quantitatively measured using MRI. Some 
studies identified the correlation between knee cartilage volume loss in MRI and JSN in 
radiography. Cicuttini et al reported that, in knee OA patients, the total of tibial and femoral 
cartilage volume had a modest correlation with joint space width (r=0.64), but the cartilage 
volume loss was not associated with JSN over 2 years [50]. Similarly, a prospective study did 
not find a significant correlation between cartilage volume loss and JSN over a 10-year follow-
up [51]. However, a nested case-control study reported that medial femoral cartilage volume 
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loss was strongly associated with radiographic progression (defined by medial tibiofemoral 
JSN >0.7 mm) in those with or at high risk of knee OA [52]. The inconsistent findings may be 
due to the limitation of radiography in assessing structural changes as we discussed in Section 
1.2.1. The association between cartilage volume loss and knee replacement has also been 
described in several studies. A study among knee OA patients reported that every 1% increase 
of the rate of tibial cartilage volume loss was independently predicted a 20% increase risk of 
undergoing a knee replacement at 4 years [53]. Moreover, a narrative review concluded that 
cartilage volume loss was a viable MRI parameter, which could predict knee replacement in a 
continuous manner [54]. Thus, the cartilage volume loss assessed in MRI has been suggested 
as a better indicator of knee OA progression and was usually set as a primary outcome in 
clinical trials [28, 55].  
 
Despite the wide use of cartilage volume in knee OA research, it can be greatly affected by 
subchondral bone area [56]. Several studies assessed the predictive value of cartilage thickness 
in knee OA, which is independent of bone area. A nested case-control study reported that loss 
of medial femorotibial cartilage thickness was strongly associated with radiographic 
progression (OR 4.0, 95% CI 2.9, 5.3) and weakly associated with pain progression (OR 1.3, 
95% CI 1.1, 1.6) [57]. A longitudinal study extended these findings and reported that the 
concurrent cartilage thickness loss (occurred in the 2-year follow-up) was associated with the 
radiographic progression (OR 3.4, 95% CI 2.6, 4.3) and symptomatic progression (OR 1.5, 95% 
CI 1.2, 1.7) over 2 years, whereas the preceding cartilage thickness loss (occurred in the past 2 
years before baseline) was only associated with the radiographic progression (OR 1.3, 95% CI 
1.1, 1.5) but not the symptomatic progression [58]. Moreover, a recent study identified the 
trajectories of medial femorotibial cartilage thickness at baseline, 1 and 2 years in those with 
or at high risk of knee OA, and determined the optimal model with 3 distinct trajectories: stable 
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(mean change = -0.08 mm), moderate decline (mean change = -0.75 mm), and greatest decline 
(mean change = -1.38mm) [59]. The study suggested that the two progression trajectories 
combined was associated with knee pain progression over 2 years (OR 1.99, 95% CI 1.34, 2.97) 
and incidence of knee replacement over 4 years (OR 4.34, 95% CI 1.62, 11.62) [59]. Thus, the 
measurement of cartilage thickness has also been accepted as an imaging biomarker and was 
used in clinical trials [60, 61]. 
 
Subchondral bone area may also play a role in knee OA. A prospective study in older adults 
reported that baseline tibial bone area predicted the incidence of following cartilage defects 
(OR 1.6-2.4 per z-score increase) and medial tibial cartilage volume loss (β -34.9 mm3 per z-
score increase) over 2.7 years [62]. Similarly, a nested case-control study in knees with mild-
to-moderate radiographic OA reported that the 24-month change of bone area across all the 
compartments (including medial and lateral femur, tibia and patella) were associated with the 
combination of radiographic and pain progression over 48 months (OR 1.28-1.71 per z-score 
increase) [63]. However, larger bone area in childhood or young adults has been suggested 
having physiologic benefits, as the physiological accrual can distribute joint loading over a 
larger surface [64]. 
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1.3 Modifiable risk factors of knee OA 
1.3.1 Obesity/overweight 
Obesity/overweight has long been recognized as a risk factor of knee OA. A meta-analysis of 
cohort studies in older adults (≥50 years) reported that being overweight/obese was associated 
higher risk of the onset of knee pain (Overweight: OR 1.98, 95% CI 1.57, 2.20; obesity: OR 
2.66, 95% CI 2.15, 3.28) [65]. Similarly, another meta-analysis reported that, compared to 
healthy participants, the BMI was higher in adults with patellofemoral pain (standardised mean 
difference (SMD) 0.24, 95% CI 0.12 to 0.36) and patellofemoral OA (SMD 0.73, 95% CI 0.46 
to 0.99) [66]. Recent studies provided further evidence which confirmed that obesity is a major 
risk of knee OA. A longitudinal study reported that baseline obesity was associated with higher 
risk of incident radiographic knee OA over 5 years among community-dwelling older adults 
(Relative risk (RR) 1.87, 95% CI 1.46, 2.40) [67]. Similarly, a nested case-control study 
reported that BMI was associated with higher risk of incident radiographic knee OA over 2 
years (OR 1.51/kg/m2, 95% CI 1.20, 1.90) [68].  
 
The effects of obesity/overweight on MRI-based knee structures were also identified in 
previous studies. A systematic review of observational study examined the relationships 
between obesity and knee cartilage, and reported that BMI has a consistent detrimental effect 
on cartilage defects and a modest detrimental effect on cartilage volume loss [69]. A recent 
cross-sectional analysis among asymptomatic people (40-79 years) reported that people of 
overweight status (BMI≥25) had a 3-fold increased odd of having cartilage defects [70]. 
Collins et al. evaluated the in vivo data of knee cartilage mechanics and composition under the 
influence of obesity, and reported that the strains and T1ρ relaxation times in tibiofemoral 
cartilage were increased in obese people, which resulted in the reduction of tibial cartilage 
thickness [71]. Similarly, there was a systematic review reported the moderate evidence from 
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observational studies supporting the relationship between BMI and the prevalence and 
incidence of knee BMLs [72]. A recent longitudinal study reported that, in overweight/obese 
women without clinical knee OA, participants with weight gain (average 8.6 kg) over 2.5 years 
would have a 1.62 odd of the progression of patellofemoral BMLs compared to those with 
stable weight [73]. 
 
Although there is a well-established link between obesity and knee OA, most of previous 
studies were conducted among middle-aged to older adults, with few studies identified the 
relationships during early life. A population-based British birth cohort reported that the 
association between BMI and later clinical knee OA (assessed by ACR criteria) became 
significant at 20 years in men and 15 years in women [74]. In addition, Gelber et al. reported 
that higher BMI in young men (aged 20-29 years) was associated with higher risk of subsequent 
knee OA (self-reported) during a median follow-up of 36 years [75]. These findings suggested 
that obesity/overweight in young adults could be a risk of knee OA development. However, no 
study identified the associations between obesity/overweight and MRI-based knee structures 
in young adults. Moreover, a longitudinal study reported that childhood overweight was 
independently associated with higher risk of adult knee pain in young men (RR 1.68, 95% CI 
1.06, 2.65), suggesting childhood overweight may have long-term detrimental effects on knee 
joint health [76]. However, no study reported the effects of overweight in childhood on knee 
structures in young adults. 
 
1.3.2 Body composition 
In addition to obesity, body composition also attracted attention in knee OA research, as it can 
distinguish the effects from different components of body weight (fat mass and lean mass). A 
recent meta-analysis of observational studies examined the association between fat mass and 
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knee OA (including radiographic, symptomatic and self-reported knee OA) [77]: fat mass was 
consistently associated with higher risk of knee OA in either case-control studies, cross-
sectional studies or cohort studies, with the fat mass in those with knee OA being higher than 
in the those without knee OA (mean difference (MD) 4.38, 95% CI 2.84, 5.92); in particular, 
the higher risk of knee OA for fat mass was consistently reported in cohort studies (RR ranged 
1.03-1.88). The meta-analysis also reported that the lean mass in those with knee OA was 
slightly higher than that in those without knee OA (MD 0.95, 95% CI -0.44, 2.34); this result 
may be due to the insufficient adjustment for body size in most studies, as the lean mass 
percentage was significantly and negatively associated with the risk of knee OA (pooled OR 
0.65, 95% CI: 0.46‐0.92).[77]. 
 
The relationship between body composition and knee cartilage was also identified in some 
studies. A community-based cohort (participants aged 40-69 years) reported that baseline fat 
mass predicted the higher risk of knee cartilage defects over 10 years (OR 1.04/kg, 95% CI 
1.00, 1.07) [78]. A prospective study among older adults (aged 51-81 years) reported that 
baseline fat mass was associated with higher medial tibial cartilage volume loss over 2.9 years 
(β -0.10% per annum/kg, 95% CI -0.17, -0.03) [79]. On the contrary, lean mass has been 
associated with higher tibial cartilage volume cross-sectionally (β 46.0 mm3/kg, 95% CI 23.0, 
69.0) [80], higher tibial cartilage volume 10 years later (β 48.4 mm3/kg, 95% CI 27.9, 68.9) 
[78] and lower cartilage volume loss in lateral tibia over 2.9 years (β -0.13% per annum/kg, 
95% CI 0.04, 0.22) [79]. Most of previous studies were conducted among middle-aged to older 
adults, with only one study described the association between body composition and tibia 
cartilage volume in young adults. In that study, fat mass was negatively (β -11.8 mm3/kg, 95% 
CI -22.2, -1.4) but lean mass was positively (26.4 mm3/kg, 95% CI 13.6, 39.1) associated with 
tibial cartilage volume measured 5 years later [81]. However, that study was only focusing on 
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the tibia site, but not the whole knee joint (including tibia, femur and patella), and only used 
the cartilage volume, but not the other independent parameters (cartilage thickness and bone 
area) of knee joint morphology. 
 
1.3.3 Physical activity and physical performance 
Physical activity is defined as any bodily movement produced by skeletal muscles that results 
in energy expenditure above resting (basal) levels, including all the activities done during 
exercise, daily living, occupation, leisure and active transportation. A recent umbrella review 
evaluated the evidence from systematic reviews, meta-analyses and pooled analyses during 
2011-2018 regarding the effects of physical activity on knee OA, and reported that, among a 
total of 24,583 participants from 240 studies, physical activity was consistently associated with 
the reductions in pain (SMD 0.53) and improvements in physical function (SMD 0.76) and 
health-related quality of life (SMD 0.28) for knee OA [82]. An updated systematic review 
summarized the results from 33 RCTs which were published in 2018-2019, and reported that 
exercise intervention can effectively improve clinical symptoms in knee OA [83]. Moreover, 
in the 2018 EULAR recommendations for physical activity in people with knee OA, promoting 
physical activity was strongly recommended to be an integral part of standard care throughout 
the course of disease [84]. In contrast, the associations between physical activity and knee 
structures are remaining undetermined. Bricca et al. reported that female knee OA patients with 
moderate physical activity (defined by the Physical Activity Scale for the Elderly) had less 
cartilage thickness loss over 4 years compared to those with low physical activity (MD 0.09 
mm, 95% CI 0.02, 0.16) [85]. However, another prospective study did not find associations 
between daily walking and radiographic worsening or MRI-based cartilage loss over 2 years in 
people at risk or with mild knee OA (K-L grade ≤2, aged 50-79 years) [86]. Moreover, a recent 
meta-analysis of RCTs investigated the effects of long-term exercise therapy (>6 months) for 
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people with knee OA, and did not find significant treatment effects from exercise on 
tibiofemoral radiographic disease severity or knee cartilage morphology [87]. 
 
Physical performance, defined as one’s ability to carry out activities requiring specific physical 
actions, may also be associated with knee OA. A longitudinal analysis reported that, among 
people with medial meniscal pathology but without knee OA, those in the highest tertile of 
knee extensor strength had lower risk of the incident radiographic knee OA compared to those 
in the lowest tertile over 2 years (RR 0.52-0.56) [88]. A prospective study among the women 
with frequent knee pain reported that higher baseline knee extensor strength was associated 
with lower risk of following knee replacement over 7 years (HR 0.99/Nm, p<0.0001) and the 
poorer baseline stand performance (time of 5 chair standing without using hands) predicted the 
incident knee replacement within 2-2.5 years (OR 1.04/s, 95% CI 1.00, 1.08) [89]. Moreover, 
a recent nested case-control study investigated the association between physical performance 
and knee cartilage, and reported that a series of performance measures, including 20-m walk 
test, 5-min walk test, stair ascending and stair descending test, and timed up & go test, were 
significantly associated with MRI-defined knee cartilage degeneration (graded by the MRI 
Osteoarthritis Knee Score) [90]. 
 
A few studies identified the effects of physical activity and physical performance on knee 
cartilage during early life. A study among adolescents (9-18 years) reported that higher 
physical activity was associated with higher knee cartilage accrual over 1.6 years [91]. Van-
Ginckel et al. reported that a 10-week moderate running intervention could improve the 
glycosaminoglycan content of knee cartilage among young women (average aged 25 years) 
[92]. Moreover, a longitudinal study reported that physical activities measured 5 years prior 
using the long version of International Physical Activity Questionnaire were consistently 
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associated with tibial cartilage volume in young adults (β 0.30-0.54 mm3/min/week) [93]. In 
the same cohort, both childhood and adult physical performance measures (physical work 
capacity, 1.6-km long-run, 50-m short-run, sit-ups, and leg strength in childhood; physical 
work capacity, long jump, and leg strength in adulthood) were associated with higher tibial 
cartilage volume in young adults (31-41 years) [93, 94]. However, the magnitude of the 
associations with cartilage volume decreased dramatically after adjusting for bone area, 
suggesting the cartilage accrual may depend on the bone development. Thus, using both 
cartilage thickness and bone area may be required to accurately assess the associations of 
physical activity and physical performance with knee cartilage and bone morphology in young 
adults. 
 
1.3.4 Diabetes and metabolic syndrome (MetS) 
Diabetes and knee OA are commonly existing, whereas their relationship is not clear yet. 
Although a systematic review, which included the observational studies published before 
October 2016, reported that there was little evidence that impaired glucose metabolism was a 
risk factor for knee OA [95], recent studies indicated the potential detrimental effects from 
diabetes. A cross-sectional study compared the knee pain measured using the Knee injury and 
Osteoarthritis Outcome Score (0=worst pain, 100=no pain) between knee OA participants (K-
L grade ≥1) with and without diabetes, and reported that individuals with diabetes experienced 
higher pain intensity (β=-4.73, 95% CI -7.22, -2.23) [96]. Driban et al. reported that high 
glycated serum protein was associated higher risk of the K-L grade increase (OR 3.21, 95% 
1.07, 9.62) over 48 months among healthy participants (baseline K-L grade <2) [97]. The 
effects of diabetes on knee cartilage have also been identified in recent studies. Neumann et al. 
reported that diabetes was associated with more severe cartilage lesions (assessed using the 
WORMS) over 4 years among participants with K-L grade ≤2 [98]. Another study in the same 
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cohort reported that the increase of cartilage T2 relaxation time over 24 months in participants 
with diabetes was twice that in those without diabetes, suggesting diabetes may accelerate the 
knee cartilage degeneration [99]. Moreover, a cross-sectional study among older adults 
(averaged 63 years) reported that diabetes status was consistently associated with higher 
cartilage T2 texture parameters (including variance, contrast, and entropy), which are the 
indicators of early articular cartilage degeneration [100]. However, there is no recent evidence 
regarding the knee cartilage morphology. In addition, all the previous studies were conducted 
among middle to older adults, but no studies were in young adults. 
 
The MetS is characterised as central obesity, dyslipidaemia, impaired fasting glucose, and 
hypertension. Emerging evidence from basic research indicated the theoretical links between 
MetS and knee OA and suggested that related metabolic pathways and mediators could be 
potential targets for knee OA treatment [101, 102]. Recent epidemiological studies also 
extended the understanding of the role of MetS in knee OA. A population-based cohort study 
reported that MetS and its components were associated with a 2-fold risk of belonging to the 
worse pain trajectory (consistently moderate pain) over 10 years [103]. The secondary analysis 
of that study suggested that the results were similar in those with radiographic knee OA. This 
was consistent with other three case-control studies, where MetS and its components were 
associated more severe knee pain in knee OA patients [104-106]. However, the association 
between MetS and the onset of knee OA has not been established. A recent systematic review 
summarised the published literature up to May 2018, and reported that the causal relations 
between MetS and knee OA cannot be determined due to the limited quality of available 
evidence and insufficient data [107]. After that, Lee et al. used the cross-sectional data (n=8491) 
from a national survey of South Korea, and reported that MetS was significantly associated 
with radiographic knee OA in women (OR 1.61, 95% CI 1.38, 1.87), but not in men [108]. In 
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contrast, the other cross-sectional data among British women (n=952, aged 45-65 years) did 
not find significant associations for MetS and knee OA [109]. Moreover, a nationally 
representative population sample of Finland (n=6274) reported that neither MetS nor its 
components increased the incident knee OA during a 32-year follow-up [110]. There are only 
two studies regarding the association between MetS and MRI-based knee cartilage measures. 
Jungmann et al. reported that MetS was cross-sectionally associated with higher T2 relaxation 
time (MD 1.2 ms, 95% CI 0.3, 2.1) among adults without knee OA (45-60 years) [111]. In the 
other study, MetS was associated with medial tibial cartilage volume loss over 10.7 years (β -
0.30% per annum, 95% CI -0.46, -0.13) among a population-based sample (57-69 years) [112]. 
However, both of the studies were conducted among middle-aged to older adults, with no 
evidence in young adults. 
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1.4 Research questions and hypotheses 
Given the background reviewed above, this thesis aimed to describe the associations between 
the modifiable factors in early life and the MRI-based knee structural measures in young adults. 
The detailed research questions and hypotheses are listed below. 
 
Chapter 3: To describe the associations between childhood adiposity measures and adult knee 
cartilage defects and BMLs measured 25 years later. 
 
Research questions: 
a) Are childhood adiposity measures associated with adult cartilage defects or BMLs? 
b) If present, are the associations independent of adult adiposity? 
 
Hypotheses: 
a) Childhood adiposity measures are associated with adult cartilage defects and BMLs. 
b) The present associations are independent of adult adiposity. 
 
Chapter 4: To describe the associations of adiposity measures in childhood and adulthood 
with knee cartilage thickness, volume and bone area in young adults. 
 
Research questions: 
a) Are childhood adiposity measures associated with adult knee cartilage thickness, volume 
and bone area? 
b) Are adult adiposity measures associated with adult knee cartilage thickness, volume and 
bone area? 
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c) Are the changes of adiposity measures from childhood to adulthood associated with adult 
knee cartilage thickness, volume and bone area? 
 
Hypotheses: 
a) Childhood adiposity measures are associated with adult knee cartilage thickness, volume 
and bone area. 
b) Adult adiposity measures are associated with adult knee cartilage thickness, volume and 
bone area. 
c) The changes of adiposity measures from childhood to adulthood are associated with adult 
knee cartilage thickness, volume and bone area. 
 
Chapter 5: To describe associations of body composition, physical activity and physical 
performance with knee cartilage thickness and bone area in young adults. 
 
Research questions: 
a) Is body composition associated with knee cartilage thickness and bone area in young adults? 
b) Is physical activity associated with knee cartilage thickness and bone area in young adults? 
c) Is physical performance associated with knee cartilage thickness and bone area in young 
adults? 
d) Are the significant associations independent of each other? 
 
Hypotheses: 
a) Body composition is associated with knee cartilage thickness and bone area in young adults. 
b) Physical activity is associated with knee cartilage thickness and bone area in young adults. 
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c) Physical performance is associated with knee cartilage thickness and bone area in young 
adults. 
d) The significant associations may be not independent of each other. 
 
Chapter 6: To describe the associations of glucose homeostasis and MetS measures with knee 
cartilage defects and cartilage volume in young adults. 
 
Research questions: 
a) Are glucose homeostasis measures associated with knee cartilage defects or cartilage volume? 
b) Are MetS measures associated with knee cartilage defects or cartilage volume? 
 
Hypotheses: 
a) Glucose homeostasis measures are associated with knee cartilage defects and cartilage 
volume. 
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In 1985, the Australian Schools Health and Fitness Survey (ASHFS) was conducted to provide 
benchmark data on the health and fitness of Australian school children using a nationally 
representative sample. Two-stage probability sampling was used for the ASHFS to randomly 
select schools and then children within age groups in the schools. The details of enrolment of 
the ASHFS was published elsewhere [113]. 8498 children (aged 7-15 years) were selected in 
ASHFS. All the children provided assent and parents provided written informed consent. 
ASHFS was approved by the State Directors General of Education. The childhood measures in 
this thesis were collected in ASHFS. 
 
During 2004-2006, the participants of ASHFS were invited to participated in the Childhood 
Determinants of Adult Health (CDAH) study, which is the 20-year follow-up of ASHFS. The 
details of enrolment of the CDAH study was published elsewhere [114]. Participants attended 
clinics which were located at sites in major cities and regional centres around Australia. 2410 
participants (aged 26-36 years) completed the clinic visit. All the participants provided written 
informed consent. The study was approved by the Southern Tasmania Health and Medical 
Human Research Ethics Committee (HREC) (Ethics Approval Number: H0008152). The adult 
measures in this thesis were collected during the CDAH clinic visit. 
 
During 2008-2010, the participants of CDAH study were invited to participated in the CDAH 
Knee Cartilage study, which is a sub-study of the CDAH study. Participants residing in 
metropolitan Melbourne and Sydney were invited by mail. Participants who agreed to 
participate were assessed for eligibility. Exclusion criteria included being pregnant, having 
diseases that might affect knee cartilage (including rheumatoid arthritis, ankylosing 
spondylitis, juvenile idiopathic arthritis and psoriatic arthritis) or having magnetic resonance 
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imaging (MRI) contraindications. The remaining participants were asked to complete a 
computer-assisted telephone interview, with knee injury history recorded. Childhood knee 
injury history was recorded in response to the question “Have you had a knee injury requiring 
non-weight bearing treatment more than 24 hours or surgery during childhood?”. Adult knee 
injury history was recorded in response to the question “Have you had a knee injury requiring 
non-weight bearing treatment more than 24 hours or surgery in your adult life?”. Then the 
participants were requested to have the knee MRI scan at Epworth Hospital in Melbourne or 
North Shore Private Hospital in Sydney. 330 participants (aged 31-41 years) completed the 
knee MRI scans. All the participants provided written informed consent. The study was 
approved by the Southern Tasmanian Health and Medical HREC, the Monash University 
HREC and the Northern Sydney and Central Coast Area HREC (Ethics Approval Number: 
H0009828). The knee structural measures in this thesis were measured from the knee MRI 
scans. 
 
The flowchart of the selection of participants for this thesis is shown in Figure 2.1. 
 






           Figure 2.1 Flowchart showing selection of the participants in this thesis 
           CDAH Study, Childhood Determinants of Adult Health Study; MRI, magnetic resonance imaging. 
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2.2 Anthropometric measurements 
2.2.1 Childhood anthropometric measurements 
In ASHFS, weight was measured to the nearest 0.5 kg using regularly calibrated scales with 
shoes, socks and bulky clothing removed. Height was measured to the nearest 0.1 cm using a 
Kawe height tape with shoes and socks removed. Body mass index (BMI) was calculated as 
weight in kilograms divided by height in meters squared. Childhood overweight status was 
defined according to age and sex-specific cut-off points [115]. 
 
Triceps, biceps, subscapular, and supra-iliac skinfolds were measured at locations determined 
by reference to anatomical landmarks [116] to the nearest 0.1 mm using Holtain Skinfold 
Calipers. All the data collectors were trained. Body density was estimated from the log of the 
sum of four skinfolds using age-specific regression equations [116, 117]. Estimate of percent 
body fat was derived from body density [118], Fat mass and lean mass were estimated by the 
percent body fat: fat mass = fat (%) × weight (kg); lean mass = weight - fat (%) × weight (kg). 
 
Waist circumference and hip circumference were measured to the nearest 0.1 cm using a 
constant tension tape. Waist-hip ratio (WHR) was calculated by dividing waist circumference 
in centimetre by hip circumference in centimetres. 
 
2.2.2 Adult anthropometric measurements 
In the CDAH study, weight was measured to the nearest 0.1 kg using digital Heine portable 
scales (Heine, Dover, NH, USA) with shoes, socks and bulky clothing removed. Height was 
measured to the nearest 0.1 cm using a stadiometer (Invicta, Leicester, UK) with shoes and 
socks removed. Body mass index (BMI) was calculated as weight in kilograms divided by 
height in meters squared. Adult overweight status was defined as a BMI ≥25 kg/m2. 




Triceps, biceps, subscapular, and supra-iliac skinfolds were measured at locations determined 
by reference to anatomical landmarks [117, 119] to the nearest 0.1 mm using Slim Guide 
Skinfold Calipers (SPRI Products). All the data collectors were trained. Body density was 
estimated from the log of the sum of four skinfolds using Durnin’s equation; the slope and 
intercept of the equations for each age- and sex-specific group have been published elsewhere 
[117, 119]. An estimate of the percent body fat was derived from body density using Siri’s 
equation: fat (%) = (4.95/density-4.50) × 100 [118]. Fat mass and lean mass were estimated by 
the percent body fat: fat mass = fat (%) × weight (kg); lean mass=weight - fat(%) × weight (kg). 
 
Waist circumference and hip circumference were measured to the nearest 0.1 cm using a 
constant tension tape. WHR was calculated by dividing waist circumference in centimetre by 
hip circumference in centimetres. 
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2.3 Physical activity measurements 
The physical activity measurements were collected during the CDAH study. Physical activity 
was assessed using the long version of the International Physical Activity Questionnaire. 
Participants were asked to report the total time (minutes) and frequency (times/week) of 
occupational, commuting, domestic and leisure activity during the past week. Physical 
activities were calculated by multiplying frequency by duration to represent the minutes per 
week of vigorous, moderate and walking activity. Time spent in each domain was summed to 
provide the estimate of total minutes of physical activity. 
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2.4 Physical performance measurements 
The physical performance measurements were collected during the CDAH study. All the 
measurements were collected by the trained data collectors based on a documented protocol. 
All the participants were shown how to complete the measurements before the formal 
collections. The participants were asked to perform with their maximal effort during the formal 
collections. The standing long jump was measured by asking the participants to stand on the 
gym mat with toes behind the line and with feet slightly apart. A two-foot take-off and landing 
was used, with the participants swinging the arms and bending the knees to provide the drive 
for jump. The landing point at the closest part of the heel to the starting line was marked and 
the distance to the starting line was measured. Right and left hand grip strength was measured 
as participants gripped the dynamometer (Smedley dynamometer, TTM, Tokyo, Japan) with 
maximum force in one hand, with the higher of two measurements recorded. Hand grip strength 
was determined by calculating the average of right and left hand grip strength. Leg strength 
was measured using a leg-back dynamometer (Muscle Meter, TTM, Tokyo, Japan) by standing 
flat-footed on a platform with a straight back flat against a wall. A hand bar was held with an 
overhand grip and knees were flexed at an angle of 115°, at which point the bar was attached 
to the dynamometer by a chain. The bar was then pulled as far upwards as possible by sliding 
the body up the wall. Physical work capacity at a heart rate of 170 bpm (PWC170) was assessed 
using a Monark bicycle ergometer. Participants were asked to cycle at a constant 60 rpm for 3 
min each at three successively increasing but submaximal workloads. Heart rate was recorded 
at 1 min intervals at each workload using an electronic heart rate monitor. PWC170 was 
calculated by linear regression with extrapolation of the line of best fit to a heart rate of 170 
bpm. 
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2.5 Glucose homeostasis measurements 
Glucose homeostasis measurements were collected in the CDAH study. Fasting glucose and 
insulin levels were measured using venous blood samples collected from the antecubital vein 
after a 12-hour fast. An Olympus AU5400 automated analyser (Olympus Optical, Tokyo, Japan) 
was used to enzymatically measure fasting glucose. A microparticle enzyme immunoassay kit 
(AxSYM; Abbot Laboratories, Abbot Park, IL) or an electrochemiluminescence immunoassay 
(Elecsys Modular Analytics E170; Roche Diagnostics, Mannheim, Switzerland) with inter-
assay standardisation was used to measure fasting insulin. Glucose homeostasis measures, 
including homeostatic model assessment 2-insulin resistance (HOMA2-IR), HOMA2-beta cell 
function (HOMA2-β) and HOMA2-insulin sensitivity (HOMA2-S), were calculated by a 
homeostasis model assessment calculator (version 2.2.3 available from 
http://www.dtu.ox.ac.uk/homacalculator) using fasting glucose and fasting insulin. 
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2.6 Metabolic syndrome (MetS) measurements 
MetS measurements were collected in the CDAH study. MetS was defined using the 
harmonized definition [120]. Five components of MetS and their thresholds were proposed in 
the definition. MetS was diagnosed when at least three of the five components were present. 
The details of MetS definition and thresholds of MetS components have been published 
elsewhere [120]. We use the following methods to collect the MetS measures: Waist 
circumference was measured at the narrowest point between the lower costal border and the 
iliac crest to the nearest 0.1 cm using a constant tension tape; high waist circumference was 
defined as waist circumference ≥102 cm in males or ≥88 cm in females. Fasting glucose was 
measured as described in glucose homeostasis measurements; hyperglycaemia was defined as 
fasting glucose of ≥5.6 mmol/L. Triglyceride and high-density lipoprotein cholesterol (HDL-
C) were measured enzymatically using an Olympus AU5400 automated analyser (Olympus 
Optical, Tokyo, Japan). Hypertriglyceridemia was defined as serum triglycerides ≥ 1.7 
mmol/L, and low HDL-C was defined as HDL-C <1.03 mmol/L in males or <1.3 mmol/L in 
females. Resting systolic and diastolic blood pressure readings were recorded after 5 min of 
quiet sitting using an OMRON HEM907 Digital Automatic Blood Pressure Monitor (Omron 
Healthcare Co., Ltd., Kyoto, Japan), and the mean of three recordings was used. Hypertension 
was defined as blood pressure ≥ 130/85 mmHg. 
 
  
Chapter 2: Methods 
37 
 
2.7 MRI measurements 
2.7.1 MRI collections 
Knee MRI scans were collected in the CDAH Knee Cartilage study. MRI scans were obtained 
from 2 hospitals, which used the same type of machine (General Electric Medical Systems, 
Milwaukee, WI, USA). Knees were imaged on a 1.5 T whole-body magnetic resonance unit 
with use of a commercial transmit-receive extremity coil. The following image sequences were 
used: (1) a T1-weighted, fat-suppressed 3-dimensional (3D) spoiled gradient-recalled 
acquisition in the steady state; flip angle 55°; repetition time 58 msec; echo time 12 msec; field 
of view 16 cm; 60 partitions; 512×512-pixel matrix; acquisition time 11 min, 56 s; 1 acquisition. 
Sagittal images were obtained at a partition thickness of 1.5 mm and an in-plane resolution of 
0.31×0.31 mm (512×512 pixels). (2) Proton density-weighted fat-suppressed two-dimensional 
fast spin-echo coronal images at a partition thickness of 3.3 mm and an in-plane resolution of 
0.31×0.31 mm (512×512 pixels); repetition time 3800 msec; echo time 45 msec. In each 
structural measurement, we randomly selected 20 participants and re-measured their scans, so 
as to assess the intraclass correlation coefficient (ICC). There were at least 2 weeks between 
the two measurements. 
 
2.7.2 Cartilage defects 
Knee cartilage defects were measured as previously reported [121] in an ordinal scale using 
the T1-weighted spoiled gradient-recalled sagittal MRI scans and proton density-weighted fast 
spin-echo coronal MRI scans together. Grade 0 indicated a normal cartilage, and Grade 1 
indicated focal blistering and low-signal intensity area in T1-weighted sagittal images or high-
signal intensity area in proton density-weighted images with intact surface/bottom. Grade 2 
indicated a loss of thickness of <50% on surface/bottom of the cartilage. Grade 3 represented 
a loss of thickness >50%, and Grade 4 indicated a full-thickness chondral wear with exposure 
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of subchondral bone. A prevalent cartilage defect was defined as a cartilage defect score of ≥
2 at any site within that compartment. Intraobserver reliability expressed as an ICC ranged 
from 0.89 to 0.94. 
 
2.7.3 Bone marrow lesions (BMLs) 
BMLs were identified using the sagittal images reformatted from coronal proton density-
weighted images and then scored as the increased signal intensity area in the subchondral bone 
adjacent to the osteochondral junction. BMLs were scored in the tibia, femur and patella using 
the ordinal scoring system previously described [39]. Participants with no BMLs were scored 
as grade 0 and then the participants with BMLs were graded according to the percentage of 
area of occupancy of BML in each compartment: grade 1: ≤25% of area; grade 2: >25% to 
<50%; grade 3: ≥50%. A prevalent BML was defined as a BML score of ≥1 at any site within 
that compartment. Intraobserver reliability expressed as an ICC ranged from 0.89 to 1.00. 
 
2.7.4 Meniscal tears 
Meniscal tear was graded in medial and lateral menisci separately based on a modified 
International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine 
meniscal tear classification system [122] using proton density-weighted coronal and T1-
weighted sagittal images. Grade 0 indicated a normal meniscus; grade 1 indicated mucoid 
degeneration; grade 2 indicated mild tear; grade 3 indicated displaced tear and grade 4 indicated 
macerated meniscus. A prevalent meniscal tears was defined as a meniscal tear score of ≥2 at 
any site within that compartment. Intraobserver reliability expressed as an ICC ranged from 
0.81 to 1.00. 
 
2.7.5 Cartilage thickness, cartilage volume and bone area 
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In Chapter 4 and Chapter 5, cartilage thickness, cartilage volume and subchondral bone area 
were measured in the medial/lateral femorotibial compartment (MFTC/LFTC) and in the 
patella as previously reported [123] by a quantitative approach, using the T1-weighted spoiled 
gradient-recalled sagittal MRI scans. A manual segmentation of knee cartilage surfaces (i.e., 
articular surface and subchondral bone interface) was performed in all of the slices depicting 
the respective cartilage structure. From the segmented voxels and 3D reconstruction of the 
cartilage surface areas, quantitative parameters of cartilage and bone morphology were derived, 
including cartilage thickness, cartilage volume and subchondral bone area, using 
Chondrometrics 3.0 Platform software (Chondrometrics GmbH, Ainring, Germany). The 
reproducibility of these measures reported in previous studies were high, with root mean square 
coefficient of variation values ranging from 1.6% to 3.2% for cartilage thickness, 1.6% to 3.4% 
for cartilage volume and 1.0% to 2.1% for bone area [124]. In chapter 4, the cartilage thickness 
and bone area in MFTC and LFTC were calculated as the sum of the area. In chapter 5, the 
cartilage thickness in MFTC, LFTC and the whole knee joint were calculated as the weighted 
average of the thickness of each compartment according to the bone area size; the bone area 
was calculated as the sum of the area of each compartment. 
 
In Chapter 6, cartilage volume was determined by means of 3D image processing on an 
independent work station using software program OsiriX (Geneva, Switzerland). Individual 
plates were isolated by manually drawing disarticulation contours around the cartilage 
boundaries on a section-by-section basis. These data were then re-sampled by means of bilinear 
and cubic interpolation (area of 312×312 μm2 and thickness of 1.5 mm, continuous sections) 
for the final 3D rendering. The coefficients of variation for cartilage volume measures were 
2.1-2.6%. Femoral cartilage volume was not measured, as it strongly correlates with tibial 
cartilage volume [125].  
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2.8 Statistical analyses 
Histograms and Q–Q plots were used to assess the normality of continuous variables. Mean 
(standard deviation), median (interquartile range) and number (percentage) were used to 
describe the characteristics of the participants. T-tests, Wilcoxon rank-sum test and Chi-square 
tests were used to assess differences in normally distributed variables, skewed variables and 
categorical variables between groups, respectively.  
 
Linear regression models were used to estimate β coefficients when the outcomes were 
continuous. For each final model, we checked whether the assumptions of linear regression 
were satisfied. Where necessary to reduce heteroscedasticity and skewness of the residuals, the 
variable was transformed (e.g. by taking logarithms). Additionally, we paid careful attention 
to the scaling of the covariates. Log binomial regression models were used to estimate relative 
risk when the outcomes were binary. Ordinal logistic regression models were used to estimate 
odds ratio when the outcomes were ordinal. In multivariable analyses, we retained the 
confounders that had important biological plausibility or changed the estimated coefficient 
by >10% [126].  
 
A 95% confidence interval not including the null point or a p-value <0.05 (two-tailed) was 
considered statistically significant. All statistical analyses were performed in Stata (Version 
14.2/15.0, StataCorp, College Station, TX, USA). 
 
In Chapter 4, weight, BMI and WHR z-scores were calculated using the entire dataset (ASHFS 
for childhood and CDAH for adulthood). The z-score changes were calculated as sex-specific 
z-score in adulthood minus age- and sex-specific z-score in childhood. 
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In Chapter 5, when significant associations disappeared and effect sizes decreased dramatically 
after adjusting for a potential mediator, we performed mediation analysis. We used the Stata 
command medeff to separate the total effect into direct effect and indirect effect. This generated 













Chapter 3: Association of childhood adiposity measures with 
adulthood knee cartilage defects and bone marrow lesions 
 
(Meng T et al. Osteoarthritis and Cartilage. 2018 Aug; 26(8):1055-1062.) 
 
  




Osteoarthritis (OA) is the most common joint disease, which is characterised by joint structural 
changes including cartilage degradation and subchondral bone abnormalities [128]. About 13% 
of women and 10% of men aged 60 years or older have symptomatic knee OA [129], with no 
approved disease modifying treatments available. Thus, identifying modifiable factors that can 
prevent knee OA is critically important. 
 
Cartilage defects and bone marrow lesions (BMLs) are important imaging biomarkers for the 
incidence and progression of knee OA. They are common in both healthy individuals and 
symptomatic OA patients [130-132], and are associated with knee pain [37, 133], knee cartilage 
volume loss [134, 135] and subsequent knee replacement surgery [136, 137] in most studies, 
although not all associations were consistent [41, 138-140]. However, little is known about 
factors that are associated with cartilage defects and BMLs in young adults, who may not yet 
have established knee OA. This information may help develop intervention during early life to 
reduce the burden of knee OA in later life [141]. 
 
Obesity has long been recognized as a risk factor for the incidence and progression of knee OA 
[142], but the role of childhood adiposity in knee OA in later life is not well studied as most of 
current evidence is derived from middle-aged or older adults [143]. Wills et al. reported that 
body mass index (BMI) as early as 11 years in females and 20 years in males was independently 
associated with knee OA at the age of 53 [74]. Similarly, Gelber et al. reported that BMI in 
young men, aged 20-29 years, was associated with the increased risk of subsequent knee OA 
[75]. In addition, we reported that the childhood adiposity measures were associated with 
higher risk of knee pain in adulthood 25 years later [76]. These findings suggest that adiposity 
measures during early life may have long-term effects on knee joint in later life. This comes 
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particularly important as the prevalence of overweight and obesity has increased in children 
and adolescents in both developed and developing countries during 1980-2013 [144]. However, 
there is a paucity of information about the effects of childhood adiposity measures on adulthood 
cartilage defects and BMLs. Therefore, we aimed to describe longitudinal associations between 
adiposity measures in childhood and knee cartilage defects and BMLs in adulthood 25 years 
later. 
  





The Australian Schools Health and Fitness Survey (ASHFS) was completed in 1985 on a 
nationwide sample of schoolchildren (n=8498, aged 7-15 years), and a wide range of health-
related measures were collected through field and technical tests. The Childhood Determinants 
of Adult Health (CDAH) Study was a 20-year follow-up (n=2410, aged 26-36 years) of 
children who participated in ASHFS and was completed during 2004-2006, adulthood health-
related measures were collected during the CDAH Study. The CDAH Knee Cartilage Study 
(n=330, aged 31-41 years) was a sub-study of the CDAH Study and the participants completed 
knee magnetic resonance imaging (MRI) scans during 2008-2010. 
 
We used the following strategy to recruit participants from the CDAH Study. The CDAH Study 
participants (n=764) residing in metropolitan Melbourne and Sydney were contacted by mail 
and invited to participate in the CDAH Knee Cartilage Study. Participants who agreed to 
participate (n=529, response percentage 69%) were assessed for their eligibility. Exclusion 
criteria for this study were being pregnant, having had diseases that might affect knee cartilage 
such as rheumatoid arthritis, or having a contraindication for MRI. Eighty participants were 
excluded either because of the exclusion criteria or because they changed their mind. The 
remaining 449 participants were asked to complete a short computer-assisted telephone 
interview. History of knee injury or surgery was not collected in childhood in the ASHFS study 
and, therefore, telephone interviews included history of knee injury in childhood. Knee injury 
was recorded in response to the question, “Have you had a knee injury requiring non-weight-
bearing treatment for more than 24 hours or surgery?” Participants were requested to have an 
MRI scan at Epworth Hospital in Melbourne or North Shore Private Hospital in Sydney. Some 
participants (n=119) did not undergo MRI after enrolling in the study due to the long distance, 
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work or family commitments, moving interstate, becoming pregnant by the time of MRI, or 
changing their mind. Eight MRI scans were not readable for cartilage defects and three for 
BMLs due to the absence of adequate sequences. Therefore, these MRI scans were not included 
for cartilage defects or BMLs assessments. There are 322 participants included in analyses for 
cartilage defects and 327 for BMLs. A flowchart of the selection of participants for this study 
is shown in Figure. 3.1. 
 
This study was approved by the Southern Tasmania Health and Medical Human Research 
Ethics Committee (HREC), the Monash University HREC and the Northern Sydney and 
Central Coast Area HREC. All participants provided written informed consent. At baseline, all 
children provided assent and parents provided written informed consent. 
 




Figure 3.1 Flowchart showing selection of the participants in Chapter 3 
BMLs, bone marrow lesions; CDAH Study, Childhood Determinants of Adult Health Study; MRI, magnetic resonance imaging. 
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3.2.2 Anthropometric measurements 
Weight was measured to the nearest 0.5 kg in 1985 and 0.1 kg during follow-up, with shoes, 
socks and bulky clothing removed. Height was measured to the nearest 0.1 cm (with shoes and 
socks removed) using a stadiometer. BMI was calculated as weight in kilograms divided by 
height in meters squared, at both time points. Overweight status in childhood was defined 
according to age and sex-specific cut-off points [115]. Adulthood overweight status was 
defined as a BMI ≥25 kg/m2. 
 
Triceps, biceps, subscapular, and supra-iliac skinfolds were measured at locations determined 
by reference to anatomical landmarks [119] to the nearest 0.1 mm by using Holtain Skinfold 
Calipers in 1985 and Slim Guide Skinfold Calipers (SPRI Products) during CDAH Study. Body 
density was estimated from the log of the sum of four skinfolds using age-specific regression 
equations [116, 117, 119]. Estimate of percent body fat was derived from body density [118], 
and fat mass was estimated by percent body fat in kilograms: fat mass=fat%×weight. 
 
3.2.3 MRI measurements 
Participants had an MRI scan of their knees in the CDAH Knee Cartilage Study. MRI scans 
were obtained from 2 hospitals, which used the same type of machine (General Electric 
Medical Systems, Milwaukee, WI, USA). Knees were imaged on a 1.5 T whole-body magnetic 
resonance unit with use of a commercial transmit-receive extremity coil. The following image 
sequences were used: (1) a T1-weighted, fat-suppressed 3-dimensional spoiled gradient-
recalled acquisition in the steady state; flip angle 55°; repetition time 58 msec; echo time 12 
msec; field of view 16 cm; 60 partitions; 512×512-pixel matrix; acquisition time 11 min, 56 s; 
1 acquisition. Sagittal images were obtained at a partition thickness of 1.5 mm and an in-plane 
resolution of 0.31×0.31 mm (512×512 pixels). (2) Proton density-weighted fat-suppressed two-
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dimensional fast spin-echo coronal images at a partition thickness of 3.3 mm and an in-plane 
resolution of 0.31×0.31 mm (512×512 pixels); repetition time 3800 msec; echo time 45 msec. 
 
Knee cartilage defects were measured as previously reported [121] in an ordinal scale using 
the T1-weighted spoiled gradient-recalled sagittal MRI scans and proton density-weighted fast 
spin-echo coronal MRI scans together. Grade 0 indicated a normal cartilage, and Grade 1 
indicated focal blistering and low-signal intensity area in T1-weighted sagittal images or high-
signal intensity area in proton density-weighted images with intact surface/bottom. Grade 2 
indicated a loss of thickness of <50% on surface/bottom of the cartilage. Grade 3 represented 
a loss of thickness >50%, and Grade 4 indicated a full-thickness chondral wear with exposure 
of subchondral bone. A prevalent cartilage defect was defined as a cartilage defect score of ≥
2 at any site within that compartment. Intraobserver reliability expressed as an intraclass 
correlation coefficient (ICC) ranged from 0.89 to 0.94. 
 
BMLs were identified using the sagittal images reformatted from coronal proton density-
weighted images and then scored as the increased signal intensity area in the subchondral bone 
adjacent to the osteochondral junction. BMLs were scored in the tibia, femur and patella using 
the ordinal scoring system previously described [39]. Participants with no BMLs were scored 
as grade 0 and then the participants with BMLs were graded according to the percentage of 
area of occupancy of BML in each compartment: grade 1: ≤25% of area; grade 2: >25% to 
<50%; grade 3: ≥50%. A prevalent BML was defined as a BML score of ≥1 at any site within 
that compartment. Intraobserver reliability expressed as an ICC ranged from 0.89 to 1.00. 
 
Meniscal tear was graded in medial and lateral menisci separately based on a modified 
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meniscal tear classification system [122] using proton density-weighted coronal and T1-
weighted sagittal images. Grade 0 indicated a normal meniscus; grade 1 indicated mucoid 
degeneration; grade 2 indicated mild tear; grade 3 indicated displaced tear and grade 4 indicated 
macerated meniscus. A prevalent meniscal tears was defined as a meniscal tear score of ≥2 at 
any site within that compartment. Intraobserver reliability expressed as an ICC ranged from 
0.81 to 1.00. 
 
3.2.4 Cholesterol and plasma glucose measures 
Venous blood samples were collected from the antecubital vein after a 12 hour fast in CDAH 
study approximately 5 years prior to CDAH Knee study. Serum total cholesterol was 
determined enzymatically (Olympus AU5400 automated analyzer, Olympus Optical, Tokyo, 
Japan). Fasting plasma glucose levels were measured by the Olympus AU5400 automated 
analyser (Olympus, Southend-on-Sea, UK). 
 
3.2.5 Statistical analyses 
Mean (standard deviation) or number (percentage) was used to describe characteristics of the 
participants. Student's t-tests or Chi-square tests were used to assess the differences in 
continuous and categorical variables, respectively, between groups of participants. Univariable 
and multivariable log binomial regressions were used to estimate relative risk (RR) for the 
associations between childhood adiposity measures and adulthood knee cartilage defects or 
BMLs before and after adjustment for potential confounders. If the log binomial model failed 
to converge, RR was estimated by using a Poisson distribution and robust standard errors. 
Multivariable ordinal logistic regressions were used to estimate odds ratio (OR) for the 
associations between childhood adiposity measures and adulthood knee cartilage defects or 
BMLs grades after adjustment for potential confounders. Interactions between sex and 
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adiposity measures on cartilage defects or BMLs were investigated by regressing cartilage 
defects or BMLs on the product term of sex and each exposure of interest (e.g., sex×BMI). 
 
Childhood age, duration of follow-up, sex, height (if weight or fat mass was the predictor), 
childhood knee injury, meniscal tears, cholesterol and plasma glucose were examined as 
potential confounders. We further adjusted for the corresponding adulthood adiposity measure 
to explore the independent association of each childhood adiposity measure with adulthood 
knee cartilage defects and BMLs. A p-value less than 0.05 (2-tailed) was considered as 
statistical significance. All statistical analyses were performed in Stata, version 14.2. 
 
  




3.3.1 Characteristics of the participants 
A sample of 327 participants with MRI was included in this analysis. A subset (n=108) of these 
participants, who were aged 9, 12 or 15 years in 1985, had fat mass measure in childhood. 
Characteristics of the participants based on the presence of cartilage defects or BMLs are 
shown in Table 3.1. Prevalence of any cartilage defects and BMLs in the knee joint was 37.9% 
and 25.7%, respectively. The following variables were comparable between participants with 
and without cartilage defects or those with and without BMLs: sex, BMI, overweight, fat mass 
and knee injury in childhood and BMI, body weight, overweight status and knee injury in 
adulthood. However, participants with cartilage defects had significantly higher childhood 
body weight and adulthood fat mass than those without cartilage defects, and participants with 
BMLs had significantly higher childhood body weight and older age than those without BMLs 
(Table 3.1).  
  




Table 3.1 Characteristics of the participants in Chapter 3 
 
 Cartilage defects Bone marrow lesions 
 No Yes No Yes 
Childhood (n=200) (n=122) (n=243) (n=84) 
  Age (years) 10.8 (2.7) 11.2 (2.6) 10.8 (2.6) 11.4 (2.5) 
  Female, n (%) 88 (44.0) 64 (52.5) 111 (45.7) 43 (51.2) 
  Weight (kg) 38.5 (12.5) 41.8 (14.0) 38.6 (12.7) 43.0 (13.8) 
  BMI (kg/m2) 17.9 (2.3) 18.4 (2.9) 18.0 (2.5) 18.5 (2.8) 
  Overweight, n (%) 11 (5.5) 10 (8.3) 15 (6.2) 6 (7.2) 
  Fat massa (kg) 8.8 (3.7) 9.3 (4.9) 8.6 (3.9) 10.1 (4.9) 
Adulthood      
  Weight (kg) 75.1 (14.6) 77.4 (16.0) 76.2 (14.8) 75.3 (15.8) 
  BMI (kg/m2) 25.0 (3.9) 25.9 (4.4) 25.4 (4.1) 25.1 (4.2) 
  Overweight, n (%) 86 (44.6) 58 (48.7) 109 (46.6) 36 (43.4) 
  Fat massa (kg) 19.8 (6.5) 23.9 (9.7) 21.2 (8.1) 22.7 (8.7) 
 
Values are mean (standard deviation) unless otherwise stated. 
aFat mass was measured among the children aged 9, 12 and 15 years in 1985; n=62, 45, 79 
and 29, respectively. 
BMI, body mass index. 
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3.3.2 Childhood adiposity measures and adulthood cartilage defects 
Childhood body weight, BMI, overweight status and fat mass were significantly associated 
with higher risks of adulthood patellar cartilage defects in univariable analyses (Table 3.2) and 
these associations remained significant after adjustment for childhood age, duration of follow-
up, sex, childhood height (if weight or fat mass was the predictor), childhood knee injury 
(Weight RR 1.05/kg, 95% confidence interval (CI) 1.02-1.09; BMI 1.10/kg/m2, 1.02-1.19; 
Overweight 2.04/yes, 1.12-3.74; fat mass 1.13/kg, 1.03-1.23) (Table 3.2). After further 
adjustment for corresponding adulthood measure, these associations were largely unchanged 
(Weight RR 1.05/kg, 95% CI 1.01-1.09; BMI 1.10/kg/m2, 1.01-1.19; Overweight 2.22/yes, 
1.21-4.08; fat mass 1.11/kg, 95% CI 1.01-1.22) (Table 3.2, Figure 3.2). There were no 
significant associations between childhood adiposity measures and adulthood tibiofemoral 
cartilage defects in either univariable or multivariable analyses (Table 3.2). Above associations 
remained large unchanged after adjustment for metabolic risk factors (cholesterol or glucose) 
or meniscal tears. 
  




Table 3.2 Associations between childhood adiposity measures and adulthood cartilage 
defects 
 
 Univariable Multivariablea Multivariableb 
 RR (95% CI) RR (95% CI) RR (95% CI) 
Patellar    
  Weight (kg) 1.02 (1.00 to 1.03) 1.05 (1.02 to 1.09) 1.05 (1.01 to 1.09) 
  BMI (kg/m2) 1.12 (1.04 to 1.20) 1.10 (1.02 to 1.19) 1.10 (1.01 to 1.19) 
  Overweight (yes) 1.89 (1.11 to 3.23) 2.04 (1.12 to 3.74) 2.22 (1.21 to 4.08) 
  Fat mass (kg) 1.10 (1.01 to 1.19) 1.13 (1.03 to 1.23) 1.11 (1.01 to 1.22) 
Tibiofemoral    
  Weight (kg) 1.01 (1.00 to 1.03) 0.98 (0.92 to 1.04) 0.97 (0.91 to 1.03) 
  BMI (kg/m2) 1.03 (0.93 to 1.14) 0.96 (0.83 to 1.10) 0.91 (0.78 to 1.06) 
  Overweight (yes) 0.97 (0.33 to 2.88) 1.10 (0.37 to 3.23) 1.00 (0.34 to 2.94) 
  Fat mass (kg) 1.07 (0.98 to 1.18) 1.13 (0.98 to 1.29) 1.08 (0.96 to 1.20) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for childhood age, duration of follow-up, sex, height (if weight or fat mass was the 
predictor), childhood knee injury. 
bFurther adjusted for corresponding adulthood measure. 
BMI, body mass index; CI, confidence interval; RR, relative risk.  




Figure 3.2 Mean childhood weight, mean childhood BMI, childhood overweight prevalence and mean childhood fat mass for participants 
classified by patellar cartilage defect grades 
ORs and 95% CIs were from multivariable ordinal logistic regressions, which included childhood age, duration of follow-up, sex, height (if 
weight or fat mass was the predictor), childhood knee injury as confounders. 
BMI, body mass index; CI, confidence interval; OR, odds ratio. 
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3.3.3 Childhood adiposity measures and adulthood BMLs 
Childhood body weight, BMI and fat mass were not associated with adulthood BMLs in 
patellar compartments in either univariable or multivariable analyses (Table 3.3); however, 
childhood overweight status was significantly associated with adulthood patellar BMLs after 
adjustment for childhood age, duration of follow-up, sex, childhood knee injury and adulthood 
overweight status (RR: 2.87/kg, 95% CI: 1.10-7.53) (Table 3.3). There were no significant 
associations between childhood adiposity measures and adulthood tibiofemoral BMLs in 
multivariable analyses (Table 3.3); however, there was an interaction between childhood fat 
mass and sex on adulthood tibiofemoral BMLs (P=0.052), so we separated males and females 
to analyse the associations between childhood fat mass and adulthood tibiofemoral BMLs. 
Childhood fat mass was associated with a higher risk of adulthood tibiofemoral BMLs in males 
(RR: 1.19/kg, 95% CI: 1.07-1.32) (Figure 3.3), but not in females (RR: 1.01, 95 % CI: 
0.87e1.18). The association in males persisted after adjustment for childhood age, duration of 
follow-up, childhood height, childhood knee injury and adulthood fat mass (Male RR: 1.16/kg, 
95% CI: 1.01-1.37; female RR: 1.10/kg, 95% CI: 0.93-1.30). Above associations remained 
large unchanged after adjustment for metabolic risk factors (cholesterol or glucose) or meniscal 
tears. 
  




Table 3.3 Associations between childhood adiposity measures and adulthood BMLs 
 Univariable Multivariablea Multivariableb 
 RR (95% CI) RR (95% CI) RR (95% CI) 
Patellar    
  Weight (kg) 1.01 (0.99 to 1.03) 1.02 (0.96 to 1.10) 1.04 (0.97 to 1.12) 
  BMI (kg/m2) 1.05 (0.93 to 1.18) 1.06 (0.92 to 1.23) 1.11 (0.95 to 1.28) 
  Overweight (yes) 2.00 (0.78 to 5.17) 2.43 (0.95 to 6.23)c 2.87 (1.10 to 7.53) 
  Fat mass (kg) 1.05 (0.93 to 1.18) 0.96 (0.78 to 1.19) 0.94 (0.76 to 1.16) 
Tibiofemoral    
  Weight (kg) 1.02 (1.01 to 1.04) 1.01 (0.96 to 1.06) 1.01 (0.96 to 1.06) 
  BMI (kg/m2) 1.07 (0.98 to 1.16) 1.02 (0.91 to 1.14) 1.03 (0.91 to 1.18) 
  Overweight (yes) 0.56 (0.15 to 2.14) 0.71 (0.19 to 2.75) 0.74 (0.19 to 2.86) 
  Fat mass (kg) 1.07 (0.98 to 1.17) 1.06 (0.95 to 1.19) 1.07 (0.95 to 1.20) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for childhood age, duration of follow-up, sex, height (if weight or fat mass was the 
predictor), childhood knee injury. 
bFurther adjusted for corresponding adulthood measure. 











Figure 3.3 Mean childhood fat mass for males classified by tibiofemoral BMLs grades 
OR and 95% CI were from multivariable ordinal logistic regressions, which included 
childhood age, duration of follow-up, sex, height, childhood knee injury as confounders. 
BMLs, bone marrow lesions; CI, confidence interval; OR, odds ratio. 
 
  




To the best of our knowledge, this is the first study describing the longitudinal associations 
between childhood adiposity measures and adulthood knee cartilage defects and BMLs. We 
found that childhood adiposity measures were significantly associated with the increased risk 
of adulthood patellar, but not tibiofemoral cartilage defects, 25 years later. In addition, 
childhood overweight status was significantly associated with the increased risk of adulthood 
patellar BMLs. These significant associations remained largely unchanged or even increased 
after adjustment for the corresponding adulthood adiposity measure, suggesting childhood 
adiposity may have independent effects on adulthood patellar structural abnormalities. 
 
Cartilage defects indicate an early stage of cartilage damage and can predict the development 
of radiographic knee OA [40]. Previous studies reported that adiposity measures are 
consistently associated with the increased risk of knee cartilage defects among middle-aged 
adults [145] and obese populations [146]. A recent systematic review concluded that there is a 
consistently detrimental association between adiposity measures and cartilage defects, 
although it also stated the strength of evidence for these findings was limited as there were lack 
of high-quality longitudinal studies [69]. However, all previous studies were conducted among 
middle-aged or older populations, and there are no studies describing the relationships between 
adiposity measures in childhood and cartilage defects in young adults, even though early life 
adiposity may play an important role in adulthood knee OA [141]. 
 
In this study, we found significant associations between childhood adiposity measures and 
adulthood cartilage defects in the patellar compartment, even though body weight in most 
children was normal. The underlying mechanisms are unclear, while evidence from research 
among adults suggests that mechanical and metabolic factors could play roles in the detrimental 
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effects of adiposity. Firstly, the increased load caused by excess weight might be one of the 
underlying mechanisms for these significant associations, as every pound increase of body 
weight was associated with 4-fold increase in the load exerted on the knee during daily 
activities in adults [147]. This is particularly important for patella as it bears around 3 times of 
body weight during activities requiring knee extension, such as stair climbing, sit-to-stand and 
squatting [148]. Moreover, Eckstein et al. reported that the patellar cartilage was more sensitive 
to physical stress compared to tibiofemoral cartilage [149]. These are also consistent with the 
previous finding that chronic overloading is a dominant factor of anterior knee pain in 
adolescents [150]. Secondly, increasing evidence suggest that the association between obesity 
and knee cartilage could be mediated by adipocytokines [151], as the adipocytokines released 
by adipose tissue would play important roles in cartilage degradation [152]. 
 
While we observed consistent associations between childhood adiposity measures and patellar 
cartilage defects in young adults, we found no significant associations between childhood 
adiposity measures and adulthood tibiofemoral cartilage defects. The reasons are unclear. A 
recent systematic review reported that the prevalence of patellofemoral OA is high, with 39% 
in symptom-based cohorts [153]. We previously reported that the prevalence and severity of 
cartilage defects increased with age and the prevalence of patellar cartilage defects was higher 
than that of tibiofemoral cartilage defects in middle-aged adults (mean aged 45 years) [154]. 
Similarly, in this young sample, we found that the prevalence of patellar cartilage defect (24.2%) 
was higher than that in tibiofemoral compartment (14.6% excluding trochlear region). Based 
on these observations, we speculate that cartilage defects may occur in the patella prior to the 
tibiofemoral compartment, and patellar cartilage may be more sensitive and vulnerable to 
physiological stress. 
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BMLs correspond to several histopathological changes including bone marrow necrosis, bone 
marrow fibrosis and abnormal trabeculae [155]. Adiposity is associated with detrimental 
effects on BML both cross-sectionally and longitudinally. Cross-sectionally, BMI [136, 156] 
and total body fat mass [80] are associated with higher prevalence of BMLs among older adults 
or community-based adults. Longitudinally, increased BMI was a risk factor for the incidence 
of BMLs over 2 years [157] and change in BMI over 10 years was positively associated with 
the increased risk of BMLs [158]. Moreover, a recent systematic review concluded that obesity 
was a moderate risk factor for BMLs in the knee [72]. In the current study, we found that the 
associations of childhood adiposity measures with adulthood BMLs were less consistent than 
those with adulthood cartilage defects; only childhood overweight status was significantly 
associated with adulthood patellar BMLs. This may be due to the low prevalence of BMLs in 
this young population-based sample. However, our findings still suggest a detrimental effect 
of overweight status on patellar BMLs, which may result from the excessive loading of the 
joint as well as the adiposity-related metabolic mechanisms [159, 160]. In addition, we found 
that childhood fat mass was significantly associated with tibiofemoral BMLs in males, but not 
females. This is consistent with our previous finding that childhood adiposity measures were 
significantly associated with adulthood knee symptoms in men, but not in women [76]. The 
reason for the sex difference is unclear, but may suggest the different roles of fat mass in the 
development of BMLs between sexs. 
 
Strengths of our study include the use of 25-year prospective data from childhood to adulthood, 
knee MRI scans in young adults, and the objective measures of adiposity. Limitations include 
the modest retention of participants from the original cohort (ASHFS), representing <5% of 
the original participants in the ASHFS. Reassuringly, characteristics, including age, sex and 
BMI, between those included in current study and the remainder of the original cohort were 
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similar, suggesting no selection bias introduced. We used adiposity measures in childhood to 
predict MRI abnormalities in adulthood, which could be affected by adulthood fat measures as 
childhood adiposity is predictive of adulthood adiposity [161]. Reassuringly, the associations 
remained largely unchanged after further adjusting for corresponding adulthood adiposity 
measure. T1-weighted MRI assessment of cartilage defects may be susceptible to artefacts 
resulting from calcifications within the cartilage, but it has been validated as accurate and 
reproducible [162], and has been used in epidemiological studies widely [163]. We did not 
collect knee injury information in childhood, but asked the participants to recall the childhood 
knee injury history. The accuracy of this information may be limited. Moreover, the types of 
injuries were not available, which has the potential to affect our results. 
 
In conclusion, Childhood adiposity measures were associated with the increased risk of 
adulthood patellar cartilage defects and, to a lesser extent, BMLs, independent of adulthood 
adiposity measures. These results suggest that adiposity in childhood has long-term effects on 
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with knee cartilage thickness, volume and bone area in young adults 
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Knee osteoarthritis (OA) is a common joint disease worldwide and a major source of knee pain 
and dysfunction in older people [164]. There are no approved disease modifying treatments for 
knee OA; thus, identifying the early-life risk factors is an ideal strategy for preventing the 
incidence of knee OA in later life. 
 
Knee OA involves multifarious changes in the joint structures, which eventually result in joint 
dysfunction. Early changes in knee joint structure can be identified using magnetic resonance 
imaging (MRI) [164]. Studies using MRI have reported that quantitative morphologic measures, 
including changes in knee cartilage thickness, cartilage volume and subchondral bone area, are 
associated with knee OA [69, 130]. Reductions in cartilage volume and thickness were found 
to be associated with knee pain [165, 166], joint space narrowing [165, 167] and subsequent 
knee replacement surgery [54], and regarded as major outcome measures in MRI-based clinical 
trials [168, 169]. Subchondral bone underlying the cartilage is also an important knee joint 
structure, as this region functionally adapts to physiological or pathological mechanical stress 
[64, 130, 170]. Expansion of tibial bone area in older populations has been shown to predict 
cartilage damage [62] and knee replacement surgery [53]; however, the effects of knee 
subchondral bone area on knee OA in young adults are not yet studied. 
 
Previous studies have reported that early-life factors, including obesity and physical activity, 
are associated with knee OA status in adulthood [141], indicating the importance of addressing 
early risk factors of the disease. We reported that physical performance measures and physical 
activity levels in childhood [94] and young adults [93] were associated with tibial bone area 
and tibial cartilage volume in young adults, suggesting that early-life factors influence knee 
structural morphology in adulthood, which have important roles in development of knee OA. 
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Existing evidence among middle-aged or older adults reported detrimental effects of adiposity 
on the morphology of knee cartilage and subchondral bone [69, 145]. However, there are no 
studies describing the effects of adiposity during early life on knee cartilage and bone 
morphology in adulthood. We hypothesised that the childhood and adult adiposity would have 
detrimental effects on knee cartilage and bone morphology in adulthood. Therefore, we aimed 
to describe associations between adiposity measures in childhood and adulthood, and knee 
cartilage thickness, cartilage volume and subchondral bone area in young adults. 
  





The Australian Schools Health and Fitness Survey (ASHFS) was completed in 1985 on a 
nationwide sample of schoolchildren (n=8498, aged 7–15 years) and a wide range of health-
related measures were collected through field and technical tests. The Childhood Determinants 
of Adult Health (CDAH) Study was a 20-year follow-up (n=2410, aged 26–36 years) of 
children who participated in ASHFS and was completed during 2004–2006. A range of health-
related factors were measured. The CDAH Knee Cartilage Study (n=330, aged 31–41 years) 
was a sub-study of the CDAH Study and the participants completed knee MRI scans during 
2008–2010. We measured the cartilage and bone morphological parameters among 186 
participants who were residing in Melbourne in CDAH Knee Cartilage Study. 
 
We used the following strategy to recruit participants from the CDAH study. CDAH 
participants (n=764) residing in metropolitan Melbourne and Sydney were contacted by mail 
and invited to participate in the CDAH Knee Cartilage Study. Participants who agreed to 
participate (n=529, response percentage 69%) were assessed for their eligibility. Exclusion 
criteria for this study included being pregnant, having had diseases that might affect knee 
cartilage, including rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis 
and psoriatic arthritis, or having a contraindication for MRI. Eighty participants were excluded 
either because of the exclusion criteria or because they changed their mind. The remaining 449 
participants were requested to have an MRI scan at Epworth Hospital in Melbourne or North 
Shore Private Hospital in Sydney. Some participants (n=119) did not undergo MRI after 
enrolling in the study due to the long distance required to travel to have the MRI, work or 
family commitments, moving interstate, becoming pregnant by the time of MRI or changing 
their mind. A flowchart of the selection of participants for this study is shown in Figure 4.1. 




This study was approved by the Southern Tasmania Health and Medical Human Research 
Ethics Committee (HREC), the Monash University HREC and the Northern Sydney and 
Central Coast Area HREC. All participants provided written informed consent. At baseline, all 
children provided assent and parents provided written informed consent. 
 






                                        Figure 4.1 Flowchart showing selection of the participants in Chapter 4 
                                        CDAH Study, Childhood Determinants of Adult Health Study; MRI, magnetic resonance imaging. 
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4.2.2 Anthropometric measurements 
Weight was measured to the nearest 0.5 kg in 1985 and 0.1 kg at follow-up, with shoes, socks 
and bulky clothing removed. Height was measured to the nearest 0.1 cm (with shoes and socks 
removed) using a stadiometer. Waist circumference and hip circumference were measured to 
the nearest 0.1 cm using a constant tension tape. Body mass index (BMI) was calculated as 
weight in kilograms divided by height in metres squared. Overweight status in childhood was 
defined according to age- and sex-specific cut-off points, as previously published [115]. Adult 
overweight status was defined as a BMI ≥25 kg/m2. Waist-hip ratio (WHR) was calculated by 
dividing waist circumference in centimetre by hip circumference in centimetres. 
 
4.2.3 MRI measurements 
In the CDAH Knee Cartilage study, knees were imaged on a 1.5T whole-body magnetic 
resonance unit with the use of a commercial transmit-receive extremity coil. Sagittal, T1-
weighted, fat-suppressed three-dimensional (3D) spoiled gradient-recalled acquisitions in the 
steady state (flip angle 55°, repetition time 58 ms, echo time 12 ms, field of view 16 cm, 60 
partitions, 512 × 512-pixel matrix, acquisition time 11 min, 56 s, 1 acquisition) were obtained 
at a partition thickness of 1.5 mm and an in-plane resolution of 0.31×0.31 mm (512×512 pixels) 
for the morphometric analysis. 
 
Cartilage thickness, cartilage volume and subchondral bone area were measured in the 
medial/lateral femorotibial compartment (MFTC/LFTC) and in the patella as previously 
reported [123] by a quantitative approach, using the T1-weighted spoiled gradient-recalled 
sagittal MRI scans. A manual segmentation of knee cartilage surfaces (i.e., articular surface 
and subchondral bone interface) was performed in all of the slices depicting the respective 
cartilage structure. From the segmented voxels and 3D reconstruction of the cartilage surface 
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areas, quantitative parameters of cartilage and bone morphology were derived, including 
cartilage thickness, cartilage volume and subchondral bone area, using Chondrometrics 3.0 
Platform software (Chondrometrics GmbH, Ainring, Germany). The reproducibility of these 
measures reported in previous studies were high, with root mean square coefficient of variation 
values ranging from 1.6% to 3.2% for cartilage thickness, 1.6% to 3.4% for cartilage volume 
and 1.0% to 2.1% for bone area [124]. 
 
4.2.4 Statistical analyses 
Weight, BMI and WHR z-scores were calculated using the entire dataset (ASHFS for 
childhood and CDAH for adulthood). The z-score changes were calculated as sex-specific z-
score in adulthood minus age- and sex-specific z-score in childhood. Mean (standard deviation) 
or number (percentage) was used to describe characteristics of the participants. T-tests or Chi-
square tests were used to assess the differences in continuous and categorical variables, 
respectively, between groups of participants. Linear regressions were used to estimate β-values 
for the associations of adiposity measures in childhood/adulthood or the changes of adiposity 
measures with knee cartilage thickness, cartilage volume and subchondral bone area in 
adulthood before and after adjustment for potential confounders. 
 
Age and sex were included as confounders, as they were associated with the predictors 
(adiposity measures) and outcomes (cartilage and bone morphology). We further adjusted for 
height, if weight or weight z-score change was the predictor, to remove the influence of height 
on weight, and bone and cartilage morphology. A p-value < 0.05 (two-tailed) was considered 
statistically significant. All statistical analyses were performed in Stata, version 15.0.  




4.3.1 Characteristics of the participants 
A sample of 186 participants with MRI was included in this analysis. Characteristics of study 
participants are given in Table 4.1. The mean childhood and adult ages of the participants were 
10.9 and 30.4 years, respectively, with 90 (48.4%) participants in the sample being female. The 
prevalence of overweight status was 7.6% in childhood and 42.1% in adulthood. There were 
no significant differences between those in current study and the reminder of original cohort 
(ASHFS) in terms of age, sex, weight, BMI and overweight status in childhood. However, 
WHR was lower in the current sample than that in the remainder of original cohort (Table 4.1). 
The characteristics, including weight, BMI and WHR, in current sample and the reminder of 
the CDAH Study were comparable, except the lower prevalence of overweight status in the 
current sample than that in the remainder of the CDAH Study.  
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Table 4.1 Characteristics of the participants in Chapter 4 
 MRI quantitative measures P value 
 Yes No  
Childhood (n=186) (n=8312)  
  Female, n (%) 90 (48.4) 4101 (49.3) 0.797 
  Age (years) 10.9 (2.7) 10.9 (2.5) 0.887 
  Weight (kg) 39.7 (13.6) 39.9 (13.0) 0.872 
  BMI (kg/m2) 18.1 (2.7) 18.2 (2.9) 0.469 
  Overweighta (yes), n (%) 14 (7.6) 975 (11.9) 0.069 
  WHR (unit)  0.82 (0.05) 0.84 (0.06) 0.001 
Adulthood  (n=2144)  
  Weight (kg) 75.8 (15.0) 77.2 (17.4) 0.291 
  BMI (kg/m2) 25.1 (4.1) 25.8 (4.9) 0.080 
  Overweightb (yes), n (%) 77 (42.1) 1075 (50.1) 0.038 
  WHR (unit) 0.79 (0.08) 0.80 (0.07) 0.051 
  Cartilage thickness (mm)    
    Patella 2.47 (0.36)   
    MFTC 3.65 (0.47)   
    LFTC 4.15 (0.51)   
  Cartilage volume (mm3)    
    Patella 2843 (714)   
    MFTC 3363 (799)   
    LFTC 4041 (1035)   
  Bone area (mm2)    
    Patella 1081 (170)   
    MFTC 1798 (260)   
    LFTC 1825 (299)   
Values are mean (standard deviation) unless otherwise stated. 
BMI, body mass index; LFTC, lateral femorotibial compartment; MFTC, medial femorotibial 
compartment; WHR, waist-hip ratio. 
aChildhood overweight status was defined according to the age and sex-specific cut-off 
points; 
bAdulthood overweight status was defined as a BMI ≥25 kg/m2.  
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4.3.2 Childhood adiposity measures and adult knee structures 
No associations were identified between childhood adiposity measures (including weight, BMI, 
overweight status and WHR) and adult knee cartilage thickness and cartilage volume in any 
knee compartments in multivariable analyses, after adjustment for childhood age, sex and 
height (if weight was the predictor) (Table 4.2). However, childhood body weight and BMI 
were negatively associated with adult patellar bone area and the association of childhood 
overweight status with adult patellar bone area was of borderline significance (p=0.051) (Table 
4.2). The significant associations of childhood weight and BMI with adult patellar bone area 
were persistent after further adjustment for adult BMI (Weight: β=-4.75 mm2/kg, 95% 
confidence interval (CI): -8.83 to -0.68; BMI: -10.61 mm2/kg/m2, -20.58 to -0.65), with a 
reduction in β-values (14.7% and 8.1%, respectively).
Chapter 4: Adiposity during early life and knee morphology in young adults 
75 
 
Table 4.2 Associations between childhood adiposity measures and knee cartilage thickness, cartilage volume and subchondral bone area 
 Cartilage thickness (mm) Cartilage volume (mm3) Bone area (mm2) 
 β (95% CI) β (95% CI) β (95% CI) 
Patella    
  Weight, kg 0.003 (-0.008 to 0.013) -13.13 (-30.18 to 3.92) -5.57 (-9.27 to -1.87) 
  BMI, kg/m2 0.009 (-0.015 to 0.033) -23.68 (-63.88 to 16.51) -11.55 (-20.37 to -2.73) 
  Overweight, yes 0.092 (-0.102 to 0.286) -111.46 (-438.07 to 215.14) -71.66 (-143.73 to 0.42)a 
  WHR, 0.01 unit -0.003 (-0.015 to 0.009) -2.30 (-21.83 to 17.23) -0.17 (-4.49 to 4.15) 
MFTC    
  Weight, kg 0.009 (-0.003 to 0.020) 5.79 (-9.76 to 21.34) -1.07 (-5.62 to 3.48) 
  BMI, kg/m2 0.021 (-0.006 to 0.048) 25.03 (-13.07 to 63.14) 3.97 (-7.88 to 15.82) 
  Overweight, yes 0.031 (-0.188 to 0.251) 50.81 (-256.63 to 358.25) -0.39 (-95.72 to 94.94) 
  WHR, 0.01 unit 0.003 (-0.010 to 0.016) 3.07 (-15.66 to 21.81) -1.65 (-7.43 to 4.13) 
LFTC    
  Weight, kg 0.006 (-0.007 to 0.018) 3.08 (-15.57 to 21.74) -0.15 (-4.61 to 4.32) 
  BMI, kg/m2 0.017 (-0.013 to 0.047) 25.97 (-20.53 to 72.47) 6.99 (-4.92 to 18.90) 
  Overweight, yes -0.046 (-0.287 to 0.194) -50.95 (-425.66 to 323.77) 10.10 (-85.94 to 106.13) 
  WHR, 0.01 unit -0.005 (-0.020 to 0.010) -1.64 (-24.47 to 21.20) 0.03 (-5.81 to 5.88) 
 
Bold denotes statistical significance, p<0.05. 
Adjusted for childhood age, sex, height (if weight was the predictor). 
BMI, body mass index; CI, confidence interval; LFTC, lateral femorotibial compartment; MFTC, medial femorotibial compartment; WHR, 
waist-hip ratio. 
ap=0.051.
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4.3.3 Adult adiposity measures and adult knee structures 
Adult BMI and overweight status were largely not associated with knee cartilage thickness, 
cartilage volume and subchondral bone area measured 4-5 years later in multivariable analyses, 
including adult age and sex as confounders (Table 4.3). However, adult weight was positively 
associated with cartilage volume in MFTC and bone area in MFTC and LFTC (Table 4.3). The 
significant association between adult weight and cartilage volume in MFTC disappeared after 
further adjusting for corresponding bone area (β=0.06 mm3/kg, 95% CI: -4.58 to 4.71). In 
addition, WHR was significantly and negatively associated with cartilage thickness measured 
4-5 years later in both MFTC and LFTC, and the negative association between adult WHR and 
patellar cartilage thickness was of borderline statistical significance (p=0.060) (Table 4.3, 
Figure 4.2). Moreover, adult WHR was significantly and negatively associated with cartilage 
volume in both patella and LFTC, and the negative association between adult WHR and 
cartilage volume in MFTC approached statistical significance (p=0.087) (Table 4.3). 
Furthermore, adult WHR was significantly and negatively associated with subchondral bone 
area in patella and the negative association between adult WHR and bone area in LFTC was of 
borderline statistical significance (p=0.058) (Table 4.3). 
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Table 4.3 Associations between adulthood adiposity measures and knee cartilage thickness, cartilage volume and subchondral bone area 
 Cartilage thickness (mm) Cartilage volume (mm3) Bone area (mm2) 
 β (95% CI) β (95% CI) β (95% CI) 
Patella    
  Weight, kg -0.001 (-0.005 to 0.004) -0.45 (-7.10 to 6.20) -0.37 (-1.71 to 0.97) 
  BMI, kg/m2 -0.005 (-0.018 to 0.008) -11.52 (-32.88 to 9.85) -3.66 (-8.37 to 1.04) 
  Overweight, yes 0.027 (-0.081 to 0.135) -15.86 (-196.54 to 164.82) -26.72 (-66.42 to 12.99) 
  WHR, 0.01 unit -0.009 (-0.018 to 0.000)a -20.97 (-36.35 to -5.60) -4.39 (-7.79 to -0.98) 
MFTC    
  Weight, kg 0.002 (-0.003 to 0.006) 8.51 (2.47 to 14.54) 3.37 (1.73 to 5.00) 
  BMI, kg/m2 0.002 (-0.013 to 0.017) 16.13 (-4.23 to 36.49) 6.62 (0.37 to 12.87) 
  Overweight, yes 0.085 (-0.037 to 0.207) 174.22 (4.51 to 343.93) 40.45 (-12.21 to 93.11) 
  WHR, 0.01 unit -0.011 (-0.021 to -0.001) -12.86 (-27.60 to 1.89)b -1.97 (-6.55 to 2.61) 
LFTC    
  Weight, kg 0.001 (-0.004 to 0.006) 4.85 (-2.45 to 12.16) 2.08 (0.46 to 3.71) 
  BMI, kg/m2 0.002 (-0.014 to 0.018) 4.45 (-20.52 to 29.42) 2.57 (-3.82 to 8.97) 
  Overweight, yes 0.077 (-0.057 to 0.211) 93.46 (-115.28 to 302.20) 13.17 (-40.41 to 66.75) 
  WHR, 0.01 unit -0.012 (-0.023 to -0.001) -21.71 (-39.54 to -3.88) -4.45 (-9.05 to 0.15)c 
 
Bold denotes statistical significance, p<0.05. 
Adjusted for adulthood age, sex, height (if weight was the predictor). 
BMI, body mass index; CI, confidence interval; WHR, waist-hip ratio; MFTC, medial femorotibial compartment; LFTC, lateral femorotibial 
compartment.  
ap=0.060; bp=0.087; cp=0.058.  





Figure 4.2 Scatter plots and linear regression lines for associations between adulthood WHR and knee cartilage thickness. 
Linear regression lines are from models adjusted for adult age and sex. 
LFTC, lateral femorotibial compartment; MFTC, medial femorotibial compartment; WHR, waist-hip ratio. 
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4.3.4 The change of adiposity measures from childhood to adulthood and adult knee 
structures 
The change of weight z-scores or BMI z-scores from childhood to adulthood was not 
significantly associated with cartilage thickness, cartilage volume or bone area in young adults 
(Table 4.4). However, increased WHR z-score from childhood to adulthood was negatively 
associated with cartilage thickness in MFTC, cartilage volume in patella and LFTC, and bone 
area in patella (Table 4.4). The effect sizes for the negative associations between WHR z-score 
change and cartilage volume in MFTC and between WHR z-score change and bone area in 
LFTC were relatively large, although they did not reach statistical significance (p=0.059 and 
0.053, respectively) (Table 4.4). The significant associations between the change of WHR z-
score and cartilage volume disappeared in patella (β=-22.47 mm3, 95% CI: -76.94 to 31.99) 
and LFTC (β=-26.22 mm3, 95% CI: -82.03 to 29.58) after adjustment for corresponding bone 
area. 
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Table 4.4 Associations of the change of adiposity measures from childhood to adulthood with knee cartilage thickness, cartilage volume and 
subchondral bone area 
 Cartilage thickness (mm) Cartilage volume (mm3) Bone area (mm2) 
 β (95% CI) β (95% CI) β (95% CI) 
Patella    
  Weight z-score change -0.055 (-0.120 to 0.010) -36.91 (-138.17 to 64.36) -1.25 (-21.75 to 19.25) 
  BMI z-score change -0.036 (-0.092 to 0.021) 15.30 (-80.37 to 110.96) 11.49 (-9.69 to 32.66) 
  WHR z-score change -0.029 (-0.075 to 0.018) -89.95 (-166.26 to -13.64) -20.74 (-37.52 to -3.97) 
MFTC    
  Weight z-score change -0.041 (-0.117 to 0.034) -1.66 (-97.19 to 93.86) 11.33 (-14.97 to 37.62) 
  BMI z-score change -0.035 (-0.101 to 0.031) -10.23 (-82.08 to 102.54) 16.37 (-12.13 to 44.87) 
  WHR z-score change -0.056 (-0.108 to -0.005) -69.69 (-142.10 to 2.72)a -7.18 (-29.72 to 15.35) 
LFTC    
  Weight z-score change -0.042 (-0.123 to 0.040) -70.78 (-183.79 to 42.22) -13.75 (-38.89 to 11.40) 
  BMI z-score change -0.025 (-0.097 to 0.047) -31.30 (-143.73 to 81.14) -4.88 (-33.73 to 23.97) 
  WHR z-score change -0.037 (-0.094 to 0.020) -93.98 (-182.02 to -5.93) -22.29 (-44.88 to 0.31)b 
Bold denotes statistical significance, p<0.05. 
Adjusted for childhood and adulthood age, sex, childhood and adulthood height (if weight z-score change is the predictor). 
BMI, body mass index; CI, confidence interval; LFTC, lateral femorotibial compartment; MFTC, medial femorotibial compartment; WHR, 
waist-hip ratio. 
ap=0.059; bp=0.053. 




To the best of our knowledge, this is the first study describing associations between adiposity 
measures during early life and knee cartilage thickness, cartilage volume and subchondral bone 
area in young adults. We found childhood body weight and BMI were negatively associated 
with adult patellar bone area but adult body weight was positively associated with bone area in 
MFTC and LFTC, and adult WHR and the WHR change from childhood to adulthood were 
negatively associated with knee cartilage thickness, cartilage volume and subchondral bone 
area. 
 
Associations between adiposity measures and knee cartilage morphology reported in the 
literature have been inconsistent. A cross-sectional study observed that BMI was negatively 
associated with knee cartilage volume in older adults (range 52–78 years old) [171]. However, 
another study reported baseline BMI did not predict change in tibial cartilage volume 
longitudinally over 2 years in healthy middle-aged men [172]. Similarly, weight loss slowed 
loss of knee cartilage thickness over 12-month among participants in a randomised clinical trial 
of a weight loss programme [173] and studies reported that morbidly obese children and 
adolescents had increased knee cartilage lesions while normal-weight children and adolescents 
did not typically show knee joint alterations [174, 175]; in contrast, no significant difference 
in change of cartilage thickness over 1 year were observed between participants who were 
overweight and those who were of normal weight [176], and no effect of diet-induced weight 
loss, with and without combination with exercise, on a large set of knee joint structural 
outcomes was detected during the 18-month Intensive Diet and Exercise for Arthritis trial [177]. 
A recent systematic review concluded that there is limited evidence for the detrimental effects 
of obesity on knee cartilage and highlighted the paucity of evidence from high-quality cohort 
studies [69]. Most of previous studies were conducted among middle-aged or older people and 
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there were no studies describing the association of early-life adiposity measures with knee 
cartilage morphology in young adults. Furthermore, all the obesity measures used in the 
included studies were focusing on general obesity such as BMI, body weight and fat mass, 
whereas no studies have explored the effects of central obesity. 
 
Associations between adiposity measures and bone area were examined in a few studies in 
either children [178, 179] or adults [145], with conflicting findings being reported. A cross-
sectional study reported that higher BMI was associated with tibial bone enlargement among 
participants aged from 26 to 61 years [145]. However, Wosje et al. reported that higher baseline 
fat mass was associated with smaller increase in total body bone area (except for the skull) over 
3.5 years among children aged from 3 to 7 years [178]. Similarly, Goulding et al. [179] reported 
that overweight or obese children had lower bone mass and total bone area than their predicted 
values calculated from body weight during growth. Subchondral bone is a dynamic structure, 
and the increased bone area may play different roles in the development of knee joint during 
different stages of life. In older populations, increases in the tibial plateau bone area occur over 
time in both healthy people [180] and people with knee OA patients [181], and have been 
shown to depend on the mechanical stress distribution and alignment [170]. Such changes in 
subchondral bone could be maladaptive, as an outcome of remodelling of subchondral 
trabeculae (with increased extracellular matrix deposition) due to loading [130]. However, 
bone accrual during childhood or young adulthood is likely to be a physiologic rather than a 
pathologic process, as the enlargement of bone area could be an adaptive change to load-
bearing stimuli and enable distribution of loads over a larger surface [64, 170]. This is 
consistent with our previous studies, which reported positive associations between childhood 
physical performance measures and knee tibial bone area [94] and bone mass [182] in young 
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adults, suggesting tibial bone accrual from childhood to early adulthood may be a physiological 
process. 
 
In this study, childhood body weight and BMI were independently and negatively associated 
with adult patellar bone area; this suggests the potential long-term detrimental effects of 
childhood adiposity on patellar bone morphology. These results are consistent with our 
previous findings, which indicated childhood adiposity measures were associated with adult 
knee symptoms [76]. We also found that the adult weight was positively associated with bone 
area in MFTC and LFTC, but not patella; the reason for the different results between patella 
and MFTC/LFTC in adulthood are unclear but could be related to the different mechanical 
stress induced by obesity on different compartment, e.g., higher on MFTC/LFTC than on 
patella [170], which may result in larger bone area. 
 
We found that adult WHR, but not general obesity measures, was significantly associated with 
thinner cartilage in MFTC and LFTC, smaller cartilage volume in patella and LFTC, and 
smaller bone area in patella measured 4-5 years later. The associations of adult WHR with 
cartilage thickness in patella, cartilage volume in MFTC and bone area in LFTC were of 
borderline significance. These results indicate the detrimental effects of central obesity on knee 
cartilage and bone morphology in young adults. Moreover, the change of WHR from childhood 
to adulthood was negatively associated with knee cartilage and bone morphology measures. 
The significant associations of WHR changes with cartilage volume largely disappeared after 
further adjusting for corresponding bone area, suggesting the detrimental effects of WHR 
changes on cartilage may be mediated by subchondral bone area. Current findings suggest that 
in context of its impact on joint structures, the specific location of the adipose tissue is 
important, as gluteofemoral adiposity is associated with higher level of leptin and adiponectin 
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and lower levels of inflammatory cytokines [183], whereas the abdominal adiposity was more 
readily to mobilise free fatty acids [184]. In addition to higher WHR being indicative of central 
adiposity, it also indicates less muscle mass in the thigh region [185], which will result in 
reduced leg strength and thereby lead to potential knee joint structural damages [186]. 
 
We observed that the associations between adiposity measures and cartilage and bone 
morphology were largely evident in adulthood. The lack of association of childhood adiposity 
may be explained in line with the cardiovascular studies among early-life participants, which 
reported that the effect of childhood adiposity measures on cardiovascular outcomes are lower 
in magnitude [187-189] and can be reversible [187-190]. The results from a childhood 
consortium study, conducted among four prospective cohorts, reported that the participants 
who were overweight or obese in childhood and obese as adults had the highest risk on adult 
cardiovascular outcomes and those who became normal weight from being overweight in 
childhood had almost similar risks of cardiovascular events as to those who were never obese 
[187]. Cardiovascular disease and OA have shared pathophysiology [191]; therefore, the 
effects of childhood adiposity on adult knee cartilage and bone morphology may only have a 
few residual effects. In addition, this may be due to the low prevalence of overweight status 
(7.6%) in childhood, whereas around 40% were overweight in adulthood [175]. We also 
reported that childhood weight and BMI were negatively associated with patellar bone area, 
but adult weight was positively associated with bone area in MFTC and LFTC. The underlying 
reasons for these differences were unclear, but may reflect that the adiposity have different 
effects on different compartments of knee joint (weight bearing and non-weight bearing) 
between peripubertal period and adulthood. Nevertheless, our results still suggested that 
preventing obesity in both childhood and adulthood and maintaining normal weight from 
childhood to adulthood were potentially helpful in maintaining knee joint health. 




Strengths of our study include the 25-year prospective data from childhood to adulthood, knee 
MRI scans in young adults and the objective measures of adiposity. Some limitations of our 
study should be considered. First, the 186 MRI scans measured for the cartilage and bone 
morphology, representing <5% of the original participants in the ASHFS, gave us only a 
modest sample size. A formal power calculation was not performed for this study because it 
was a secondary analysis of the data collected in the main study. The key finding of scientific 
interest in this study was the negative association between adult WHR and knee cartilage 
thickness, and we performed power calculations on the analysed model with the assumption of 
α=0.05 and β=0.20. The results showed that we needed 349 participants in MFTC, 346 
participants in LFTC and 382 participants in patella to have 80% power, and our current sample 
size was lower. Therefore, the lack of statistical associations in our model should be interpreted 
carefully as we did not have enough power. Reassuringly, we still found statistically significant 
or of borderline significant associations, indicating these associations were valid. Second, the 
WHR was lower in current sample than that in the remainder of the original cohort (ASHFS) 
and the prevalence of overweight status was lower in current sample than that in the remainder 
of the CDAH Study. The lower WHR and overweight prevalence may indicate that the current 
sample comprised healthier participants and these may not bias our results as normal-weight 
children and young adults are less likely to report knee joint alterations [175, 192]. Third, we 
did not perform MRI scans among the participants at baseline, so we were unable to describe 
the longitudinal changes of knee cartilage and bone morphology over time. Fourth, we did not 
collect knee injury information in childhood, which would have impact on knee cartilage in 
later life. Thus, we were unable to adjust childhood knee injury status when we analysed the 
effects of change of adiposity measures from childhood to adulthood on knee cartilage 
thickness, volume and bone area in young adults. 




In conclusion, childhood weight and BMI were negatively but adult weight was positively 
associated with adult bone area. Adult WHR and the change in WHR from childhood to 
adulthood were negatively associated with cartilage thickness, volume and bone area. These 















Chapter 5: Association of body composition, physical activity and physical 
performance with knee cartilage thickness and bone area in young adults 
 
(Meng T et al. Rheumatology. 2020 Jul; 59(7):1607-1616.) 
 
  




Osteoarthritis (OA) is one of the most prevalent joint disorders worldwide. However, there are 
no proven therapies to arrest or delay disease progression. Therefore, identifying modifiable 
factors that can prevent OA is critically important. 
 
Magnetic resonance imaging (MRI) is a sensitive method for detecting early structural changes 
in knee OA [163]. Cartilage loss, as viewed on MRI, is regarded as the signature feature of 
knee OA [34]. Thinning of cartilage predicts knee pain and joint space narrowing over 6 months 
[165] and knee replacement surgery over 4 years [193]. Subchondral bone is also important in 
knee OA. Changes in bone area over24 months are associated with the combination of 
radiographic and pain progression over 48 months [63]. In young adults, bone area enlargement 
could be a physiological adaption to mechanical stimulation, as the enchondral ossification 
process to form larger metaphyses could distribute the stress over a larger area [64, 93]. 
Therefore, thicker cartilage and larger subchondral bone may be beneficial to maintain knee 
joint health. 
 
Body composition is associated with physical function and quality of life among OA patients, 
even among those with normal body mass index (BMI) [194]. However, body composition has 
shown inconsistent associations with knee cartilage morphology in previous studies [69]. We 
reported that fat mass was negatively associated with cartilage volume and lean mass was 
positively associated with cartilage volume in both young [81] and older adults [79], whereas 
fat mass was not associated with cartilage volume in other studies [80, 195]. Exercise is 
recommended for managing knee OA, as it improves patient outcomes related to symptoms, 
mobility, quality of life and psychological health [196, 197]. However, a systematic review 
reported that there were only a few studies that reported a positive relationship between 
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physical activity and cartilage volume among healthy participants (ages 19-79 years) [198]. 
Physical performance is a product of both muscular performance and cardiorespiratory 
performance and has been set as an important target for disease preventive strategies [199]. 
Hand grip strength is the most important indicator of whole-body muscular fitness. Lower hand 
grip strength has been associated with more severe knee radiographic OA among people >50 
years of age [200]. Similarly, physical work capacity at a heart rate of 170 bpm (PWC170) is 
a good indicator of cardiorespiratory fitness, and previous studies have reported that higher 
PWC170 is associated with higher knee cartilage volume in both young and older adults [93, 
201]. In addition to the indicators reflecting the whole-body condition, leg strength and long 
jump are important indicators of strength and power, respectively, in the lower limbs. Both leg 
strength and leg power have been associated with knee symptoms in knee OA patients [202-
204] and higher cartilage volume in young adults [93]. 
 
As bone area is a key driver of cartilage volume [56], assessing both cartilage thickness and 
bone area may be required to accurately assess knee cartilage and bone morphology. In addition, 
cartilage thickness has a close association with early knee OA [205] and has been reported as 
an imaging biomarker [34]. However, few studies have identified factors associated with 
cartilage thickness in young adults, who are the important target population for OA prevention. 
Therefore, we aimed to describe associations of body composition, physical activity and 
physical performance with knee cartilage thickness and bone area in young adults. 
  





In 1985, the Australian Schools Health and Fitness Survey (ASHFS) was conducted to provide 
benchmark data on the health and fitness of Australian school children using a nationally 
representative sample. Two-stage probability sampling was used for the ASHFS to randomly 
select schools and then children within age groups in the schools. The Childhood Determinants 
of Adult Health (CDAH) study was a 20-year follow-up of children who participated in the 
ASHFS. From 2004 to 2006, participants attended clinics that were located at sites in major 
cities and regional centres around Australia, and anthropometric measurements, physical 
activity measurements and physical performance measurements were collected during the 
clinic visit. The details of enrolment of the ASHFS and CDAH study have been published 
elsewhere [113, 114]. The CDAH Knee Cartilage Study was a sub-study of the CDAH study 
where participants completed knee MRI scans during 2008–2010. The current study is a subset 
of the CDAH Knee Cartilage Study. Due to limited funding, we measured cartilage and bone 
morphology among the participants residing in Melbourne. 
 
We used the following strategy to recruit participants from the CDAH study. Participants 
residing in metropolitan Melbourne and Sydney were invited by mail to participate in the 
CDAH Knee Cartilage Study. Participants who agreed to participate were assessed for 
eligibility. Exclusion criteria included being pregnant, having diseases that might affect knee 
cartilage (including rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis 
and psoriatic arthritis) or having MRI contraindications. The remaining participants were asked 
to complete a computer-assisted telephone interview, with knee injury history recorded. Then 
the participants were requested to have an MRI scan at Epworth Hospital in Melbourne or 
North Shore Private Hospital in Sydney. 




This study was approved by the Southern Tasmania Health and Medical Human Research 
Ethics Committee (HREC), the Monash University HREC and the Northern Sydney and 
Central Coast Area Health HREC. All participants provided written informed consent. 
 
5.2.2 Anthropometric measurements 
The anthropometric measurements were collected during the CDAH study. Weight was 
measured to the nearest 0.1 kg, with shoes, socks and bulky clothing removed. Height was 
measured to the nearest 0.1 cm, with shoes and socks removed. BMI was calculated as weight 
(kg) divided by height squared (m2). Triceps, biceps, subscapular and supra-iliac skinfolds were 
measured at locations determined by reference to anatomical landmarks [119] to the nearest 
0.1 mm using Slim Guide Skinfold Callipers (SPRI Products). Body density was estimated 
from the log of the sum of four skinfolds using Durnin’s equation; the slope and intercept of 
the equations for each age- and sex-specific group have been published elsewhere [117, 119]. 
An estimate of the percent body fat was derived from body density using Siri’s equation: fat 
(%) = (4.95/density-4.50) × 100 [118]. Fat mass and lean mass were estimated by the percent 
body fat (kg): fat mass = fat (%) × weight (kg); lean mass = weight - fat (%) × weight (kg). 
 
5.2.3 Physical activity measurements 
The physical activity measurements were collected during the CDAH study. Physical activity 
was assessed using the long version of the International Physical Activity Questionnaire 
(IPAQ-L). Participants were asked to report the total time (minutes) and frequency (times/week) 
of occupational, commuting, domestic and leisure activity during the past week. Physical 
activities were calculated by multiplying frequency by duration to represent the minutes per 
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week of vigorous, moderate and walking activity. Time spent in each domain was summed to 
provide the estimate of total minutes of physical activity. 
 
5.2.4 Physical performance measurements 
The physical performance measurements were collected during the CDAH study. Physical 
performance measurements included long jump, hand grip strength, leg strength and PWC170. 
The standing long jump was measured by asking the participants to stand on the gym mat with 
toes behind the line and with feet slightly apart. A two-foot take-off and landing was used, with 
the participants swinging the arms and bending the knees to provide the drive for jump. The 
landing point at the closest part of the heel to the starting line was marked and the distance to 
the starting line was measured. Right and left hand grip strength was measured as participants 
gripped the dynamometer (Smedley dynamometer, TTM, Tokyo, Japan) with maximum force 
in one hand, with the higher of two measurements recorded. Hand grip strength was determined 
by calculating the average of right and left hand grip strength. Leg strength was measured using 
a leg-back dynamometer (Muscle Meter, TTM, Tokyo, Japan) by standing flat-footed on a 
platform with a straight back flat against a wall. A hand bar was held with an overhand grip 
and knees were flexed at an angle of 115°, at which point the bar was attached to the 
dynamometer by a chain. The bar was then pulled as far upwards as possible by sliding the 
body up the wall. PWC170 was assessed using a Monark bicycle ergometer. Participants were 
asked to cycle at a constant 60 rpm for 3 min each at three successively increasing but 
submaximal workloads. Heart rate was recorded at 1 min intervals at each workload using an 
electronic heart rate monitor. PWC170 was calculated by linear regression with extrapolation 
of the line of best fit to a heart rate of 170 bpm. 
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5.2.5 MRI measurements 
The MRI scans were collected during the CDAH Knee Cartilage Study. Knees were imaged 
on a 1.5 T whole-body MRI unit (General Electric Medical Systems, Milwaukee, WI, USA) 
with the use of a commercial transmit–receive extremity coil. Sagittal, T1-weighted, fat-
suppressed three-dimensional spoiled gradient-recalled acquisitions in the steady state (flip 
angle 55°, repetition time 58 msec, echo time 12 msec, field of view 16 cm, 60 partitions, 
512×512 pixel matrix, acquisition time 11 min 56 sec, 1 acquisition) were obtained at a 
partition thickness of 1.5 mm and an in-plane resolution of 0.31×0.31 mm for cartilage 
morphometric analysis. 
 
Cartilage thickness and subchondral bone area were measured in the medial and lateral 
femorotibial compartment (MFTC/LFTC) and in the patella as previously reported [123] by a 
quantitative approach. Manual segmentation of knee cartilage surfaces (i.e. articular surface 
and subchondral bone interface) was performed in all the slices depicting the respective 
cartilage structure. From the segmented voxels and three-dimensional reconstruction of the 
cartilage surface areas, quantitative parameters of cartilage and bone morphology were derived, 
including cartilage thickness and subchondral bone area, using Chondrometrics 3.0 software 
(Chondrometrics GmbH, Ainring, Germany). The total knee joint cartilage thickness was 
calculated as the weighted average of the thickness of each compartment according to the bone 
area size and the total knee joint bone area was calculated as the sum of the area of each 
compartment. The absolute reliability of these measures has been assessed in young adults 
(ages 22–27 years), with a coefficient of variation of 2.5–3.9% for cartilage thickness and 1.5–
4.5% for bone area [206]. We used the same measurement system, same rater and similar 
population in the current study. 
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5.2.6 Statistical analyses 
Histograms and Q–Q plots were used to assess the normality of continuous variables. Mean 
(standard deviation), median (interquartile range) and number (percentage) were used to 
describe the characteristics of the participants. T-tests, Wilcoxon rank-sum test and Chi-square 
tests were used to assess differences in normally distributed variables, skewed variables and 
categorical variables between groups, respectively. Linear regression analysis was used to 
estimate β-values for associations of body composition, physical activity and physical 
performance with knee cartilage thickness and subchondral bone area. We retained the 
confounders that had important biological plausibility or changed the estimated coefficient 
by >10% [126]. Age (in the CDAH study), sex, height (if fat mass or lean mass was a predictor), 
BMI (if physical activity or physical performance measures were predictors), duration of 
follow-up and knee injury history were included in the analysis models. For each model, we 
checked whether the assumptions of linear regression were satisfied. Where necessary to 
reduce heteroscedasticity and skewness of the residuals, the variable was transformed (e.g. by 
taking logarithms). Additionally, we paid careful attention to the scaling of the covariates. 
 
We further adjusted for lean mass or total physical activity to explore independent associations 
of physical performance measures with knee cartilage thickness and subchondral bone area. 
When significant associations disappeared and effect sizes decreased dramatically after 
adjusting for a potential mediator, we performed mediation analysis to confirm the associations. 
We used the Stata (Stata version 15.0, StataCorp, College Station, TX, USA) command medeff 
to separate the effect of physical performance on cartilage thickness and bone area into direct 
effect (independent effect of physical performance on knee structures) and indirect effect 
(effect of physical performance on knee structures mediated by lean mass). This generated an 
estimate of the proportion of the total effect that is mediated [127]. 




A 95% confidence interval not including the null point or a p-value <0.05 (two-tailed) was 
considered statistically significant. All statistical analyses were performed in Stata version 15.0. 
  




5.3.1 Characteristics of the participants 
A total of 2410 participants completed a clinic visit during the CDAH study and 330 
participants completed MRI scans during the CDAH Knee Cartilage Study. Nonparticipation 
in the CDAH Knee Cartilage Study was related to the following: not residing in Melbourne or 
Sydney (n=1646), not responding or refusing (n=235), pregnant (n=8), rheumatoid arthritis 
(n=2), MRI contraindication (n=13), withdrawal (n=68), long distance for travelling to imaging 
site (n=103), work/family commitments (n=3) and moving interstate (n=2). A total of 186 MRI 
scans were measured for the current study, as 131 scans were not from Melbourne and 13 scans 
were unreadable. 
 
In the current study, participants were 31–41 years of age (mean 35.3) when the MRI was 
acquired and 48% were female. The time between exposure measurements and MRI scanning 
ranged from 4.01 to 5.43 years (mean 4.77). Participants in the current study were younger and 
had less fat mass, less moderate activity and greater long jump performance than those in the 
remainder of the CDAH study, whereas other characteristics were comparable (Table 5.1). 
Additionally, participants in the current study were younger and had less knee injury than those 
in the remainder of the CDAH Knee Cartilage Study (data not shown). 
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Table 5.1 Characteristics of the participants in Chapter 5 and the remainder of CDAH Study 
 MRI quantitative measures P value 
 Yes (n=186) No (n=2144)  
Agea (years) 30.4 (2.8) 31.1 (2.6) 0.002 
Sex (female), n (%) 90 (48.4) 1092 (51.0) 0.369 
BMI (kg/m2) 25.1 (4.1) 25.8 (4.9) 0.080 
Knee injury history, n (%) 21 (11.3)   
Body composition (kg)    
  Lean mass 54.4 (11.3) 54.4 (12.2) 0.981 
  Fat mass  21.4 (7.6) 22.8 (9.3) 0.043 
Physical activity (hours/week), 
median (IQR) 
   
  Walking 3.3 (1.3, 6.0) 3.0 (1.0, 6.3) 0.609 
  Moderate activity 3.8 (1.8, 6.8) 4.8 (2.2, 8.6) 0.009 
  Vigorous activity 1.0 (0.0, 3.7) 1.0 (0.0, 3.3) 0.381 
  Total activity 10.5 (5.9, 16.2) 11.0 (6.2, 17.8) 0.176 
Physical performance measures    
  Long jump (cm) 170.9 (32.6) 162.5 (36.6) 0.005 
  Hand grip strengthb (kg) 39.3 (10.4) 38.2 (11.6) 0.149 
  Leg strength (kg) 136.0 (47.0) 128.7 (51.7) 0.062 
  PWC170 (watt) 170.5 (53.0) 164.2 (51.8) 0.130 
Cartilage thickness (μm)    
  Totalc 2073 (237)   
  MFTC 1801 (221)   
  LFTC 2100 (260)   
  Patella 2473 (361)   
Bone area (mm2)    
  Totald 4704 (674)   
  MFTC 1798 (260)   
  LFTC 1825 (299)   
  Patella 1081 (170)   
Values are mean (standard deviation) unless otherwise stated. 
CDAH Study, the Childhood Determinants of Adult Health Study; MRI, magnetic resonance 
imaging; BMI, body mass index; IQR, interquartile range; MFTC, medial femorotibial 
compartment; LFTC, lateral femorotibial compartment; PWC170, physical work capacity.  
aAge during the CDAH Study.  
bCalculated as the average of right and left hand grip strength. 
cCalculated as the weighted-average according to the bone area of each compartment. 
dCalculated as the sum of each compartment. 
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5.3.2 Body composition and knee structures 
Lean mass was positively associated with cartilage thickness in the whole knee joint and in the 
MFTC and LFTC, but not the patella (Table 5.2, Figure 5.1). Fat mass was not associated with 
cartilage thickness in any sites (Table 5.2). Lean mass was positively associated with bone area 
in the whole knee joint, MFTC and LFTC, but not the patella (Table 5.2). Fat mass was not 
associated with bone area, except for the positive association between fat mass and bone area 
in the MFTC (Table 5.2). 
 




Table 5.2 Association of body composition (kg) with knee cartilage thickness and bone area 
in young adults 
 Cartilage thickness (μm) Bone area (mm2) 
 β (95% CI) β (95% CI) 
Total   
  Lean mass 6.52 (0.86 to 12.18) 13.37 (5.43 to 21.31) 
  Fat mass -2.83 (-6.94 to 1.28) 3.20 (-2.68 to 9.08) 
MFTC   
  Lean mass 7.13 (1.96 to 12.31) 8.37 (4.80 to 11.94) 
  Fat mass -1.68 (-5.49 to 2.12) 3.48 (0.80 to 6.16) 
LFTC   
  Lean mass 6.86 (0.91 to 12.81) 7.34 (3.79 to 10.88) 
  Fat mass -3.34 (-7.66 to 0.99) 0.87 (-1.80 to 3.55) 
Patella   
  Lean mass 9.00 (-0.73 to 18.72) -0.26 (-3.36 to 2.84) 
  Fat mass -3.33 (-10.36 to 3.71) -0.58 (-2.80 to 1.65) 
 
Bold denotes statistical significance, p<0.05. 
Adjusted for baseline age, sex, duration of follow-up, knee injury history and height. 
CI, confidence interval; MFTC, medial femorotibial compartment; LFTC, lateral femorotibial 
compartment.





Figure 5.1 Scatter plots and linear regression lines for associations between lean mass and knee cartilage thickness  
r and p values are from models adjusted for baseline age, sex, duration of follow-up, knee injury history, and height. 
MFTC, medial femorotibial compartment; LFTC, lateral femorotibial compartment. 
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5.3.3 Physical activity and knee structures 
Associations between physical activity measures (including walking, moderate activity, 
vigorous activity and total physical activity) and cartilage thickness and bone area in the whole 
knee or individual compartments were not statistically significant (Table 5.3). 
 




Table 5.3 Association of physical activity (hours/week) with knee cartilage thickness and 
bone area in young adults 
 Cartilage thickness (μm) Bone area (mm2) 
 β (95% CI) β (95% CI) 
Total   
  Walking  0.09 (-7.91 to 8.08) 0.06 (-16.59 to 16.72) 
  Moderate activity 2.77 (-4.88 to 10.41) -5.14 (-21.11 to 10.83) 
  Vigorous activity  4.48 (-5.32 to 14.28) -1.70 (-22.24 to 18.84) 
  Total physical activity 1.54 (-2.49 to 5.58) -1.69 (-10.12 to 6.74) 
MFTC   
  Walking  1.79 (-5.20 to 8.77) 2.89 (-3.56 to 9.33) 
  Moderate activity 0.30 (-6.71 to 7.30) -2.30 (-8.77 to 4.18) 
  Vigorous activity  3.33 (-5.43 to 12.10) -3.98 (-12.12 to 4.17) 
  Total physical activity 1.10 (-2.49 to 4.69) -0.50 (-3.83 to 2.83) 
LFTC   
  Walking  3.99 (-4.08 to 12.05) 1.30 (-5.79 to 8.38) 
  Moderate activity 5.53 (-2.52 to 13.58) -1.94 (-9.04 to 5.17) 
  Vigorous activity  9.41 (-0.64 to 19.46) 0.09 (-8.87 to 9.05) 
  Total physical activity  4.07 (-0.03 to 8.17) -0.15 (-3.80 to 3.50) 
Patella   
  Walking  -0.72 (-14.16 to 12.72) -1.20 (-6.41 to 4.00) 
  Moderate activity 3.08 (-9.80 to 15.96) -2.47 (-7.45 to 2.51) 
  Vigorous activity  -0.86 (-17.43 to 15.72) -2.55 (-8.99 to 3.89) 
  Total physical activity  0.53 (-6.27 to 7.33) -1.42 (-4.05 to 1.21) 
 
Adjusted for baseline age, sex, duration of follow-up, body mass index, knee injury history. 
CI, confidence interval; MFTC, medial femorotibial compartment; LFTC, lateral femorotibial 
compartment. 
 
Chapter 5: Correlates of knee morphology in young adults 
103 
 
5.3.4 Physical performance and knee structures 
Long jump, hand grip strength and PWC170 were associated with greater knee cartilage 
thickness in the whole joint and in most compartments (except long jump in the LFTC and 
PWC170 in the patella) (Table 5.4). These associations were largely unchanged after further 
adjustment for total physical activity (data not shown). However, most associations 
disappeared after further adjustment for lean mass, with only associations between long jump 
and knee cartilage thickness in the whole joint and patella remaining statistically significant 
(Table 5.4). There were no associations between leg strength and cartilage thickness in any 
sites (Table 5.4). All physical performance measures were positively associated with 
subchondral bone area in the whole knee joint and most individual compartments (except for 
long jump in the MFTC and hand grip strength and leg strength in the patella) (Table 5.4). 
These associations were largely unchanged after further adjustment for total physical activity 
(data not shown). However, all the significant associations disappeared after further adjustment 
for lean mass, with large reductions in the effect sizes (Table 5.4). 
 
In mediation analysis, associations between physical performance and total knee cartilage 
thickness and bone area were largely mediated by lean mass. All the indirect effects (mediated 
by lean mass) were statistically significant, whereas most of the direct effects were not 
significant (except the association between long jump and cartilage thickness) (Table 5.5). The 
percentage of the total effect mediated by lean mass ranged from 27 to 95% (Table 5.5). 
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Table 5.4 Associations of physical performance with knee cartilage thickness and bone area in young adults 
  Cartilage thickness (μm) Bone area (mm2) 
  Model 1 Model 2 Model 1 Model 2 
  β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Total 
    
  Long jump (cm) 2.44 (0.70 to 4.18) 1.78 (0.10 to 3.46) 3.99 (0.64 to 7.34) 1.26 (-1.20 to 3.72) 
  Hand grip strength (kg) 7.74 (1.50 to 13.98) 3.53 (-2.81 to 9.87) 19.06 (7.21 to 30.92) 1.70 (-7.69 to 11.09) 
  Leg strength (kg) 0.66 (-0.46 to 1.78) -0.15 (-1.27 to 0.97) 3.18 (1.09 to 5.28) 0.19 (-1.46 to 1.84) 
  PWC170 (watt) 1.07 (0.29 to 1.85) 0.37 (-0.47 to 1.20) 3.15 (1.70 to 4.60) 0.27 (-0.97 to 1.50) 
MFTC 
    
  Long jump (cm) 1.76 (0.21 to 3.31) 1.20 (-0.29 to 2.69) 1.05 (-0.30 to 2.40) 0.11 (-0.95 to 1.18) 
  Hand grip strength (kg) 6.33 (0.89 to 11.77) 2.08 (-3.55 to 7.71) 7.71 (3.06 to 12.35) 0.59 (-3.47 to 4.64) 
  Leg strength (kg) 0.62 (-0.38 to 1.62) -0.12 (-1.13 to 0.88) 1.27 (0.42 to 2.12) 0.13 (-0.59 to 0.85) 
  PWC170 (watt) 0.83 (0.13 to 1.53) 0.17 (-0.59 to 0.92) 1.01 (0.41 to 1.61) -0.17 (-0.71 to 0.37) 
LFTC 
    
  Long jump (cm) 1.43 (-0.36 to 3.22) 0.80 (-0.93 to 2.52) 1.51 (0.11 to 2.91) 0.47 (-0.58 to 1.51) 
  Hand grip strength (kg) 9.87 (3.71 to 16.03) 5.39 (-1.03 to 11.81) 10.28 (5.53 to 15.02) 2.39 (-1.54 to 6.33) 
  Leg strength (kg) 0.66 (-0.49 to 1.81) -0.21 (-1.36 to 0.95) 1.62 (0.75 to 2.49) 0.34 (-0.37 to 1.04) 
  PWC170 (watt) 1.32 (0.53 to 2.11) 0.66 (-0.21 to 1.52) 1.52 (0.92 to 2.12) 0.27 (-0.25 to 0.80) 
Patella 
    
  Long jump (cm) 5.35 (2.43 to 8.27) 4.51 (1.61 to 7.40) 1.13 (0.07 to 2.19) 0.54 (-0.41 to 1.49) 
  Hand grip strength (kg) 10.57 (0.19 to 21.33) 4.94 (-6.22 to 16.11) 2.89 (-0.98 to 6.75) -1.05 (-4.70 to 2.60) 
  Leg strength (kg) 1.19 (-0.73 to 3.10) 0.13 (-1.84 to 2.10) 0.34 (-0.35 to 1.02) -0.36 (-1.00 to 0.28) 
  PWC170 (watt) 1.12 (-0.24 to 2.47) 0.05 (-1.42 to 1.53) 0.79 (0.32 to 1.26) 0.19 (-0.29 to 0.68) 
 
Bold denotes statistical significance, p<0.05. 
Model 1 = adjusted for baseline age, sex, duration of follow-up, body mass index, knee injury history. 
Model 2 = model 1 + further adjusted for lean mass. 
CI, confidence interval; MFTC, medial femorotibial compartment; LFTC, lateral femorotibial compartment; PWC170, physical work capacity. 




Table 5.5 Mediation analysis of associations between physical performance measures and 
knee structures (mediated by lean mass) 
 
Total knee cartilage thickness (μm) Total knee bone area (mm2) 
 
Estimates (95% CI) Estimates (95% CI) 
Long jump (cm) 
  
  Indirect effect 0.65 (0.10 to 1.40) 2.68 (0.45 to 5.14) 
  Direct effect 1.75 (0.15 to 3.40) 1.22 (-1.12 to 3.63) 
  Total effect 2.40 (0.72 to 4.16) 3.90 (0.59 to 7.17) 
  Total effect mediated, % 27 (16 to 90) 68 (35 to 100) 
Hand grip strength (kg) 
  
  Indirect effect 4.17 (1.81 to 7.31) 17.21 (9.37 to 26.21) 
  Direct effect 3.41 (-2.60 to 9.63) 1.53 (-7.37 to 10.74) 
  Total effect 7.58 (1.53 to 14.08) 18.74 (7.17 to 30.40) 
  Total effect mediated, % 55 (29 to 100) 92 (57 to 100) 
Leg strength (kg) 
  
  Indirect effect 0.80 (0.37 to 1.39) 2.97 (1.58 to 4.56) 
  Direct effect -0.17 (-1.23 to 0.93) 0.16 (-1.41 to 1.78) 
  Total effect 0.63 (-0.42 to 1.79) 3.13 (1.09 to 5.19) 
  Total effect mediated, % 98 (-14 to 100) 95 (57 to 100) 
PWC170 (watt) 
  
  Indirect effect 0.70 (0.32 to 1.16) 2.87 (1.92 to 4.03) 
  Direct effect 0.35 (-0.45 to 1.17) 0.24 (-0.93 to 1.46) 
  Total effect 1.05 (0.31 to 1.86) 3.11 (1.71 to 4.54) 
  Total effect mediated, % 67 (37 to 100) 92 (63 to 100) 
 
Bold denotes statistical significance, p<0.05. 
CI, confidence interval; PWC170, physical work capacity. 
Covariates: baseline age, sex, duration of follow-up, body mass index, knee injury history. 
All estimates obtained using causal mediation analysis with Stata’s medeff command.  
Direct effects: independent effects of physical performance on knee structures.  
Indirect effect: effects of physical performance on knee structures mediated by lean mass. 
 




This is the first study describing associations of body composition, physical activity and 
physical performance with knee cartilage thickness and subchondral bone area in young adults. 
We found that greater lean mass and physical performance, but not physical activity, were 
associated with greater knee cartilage thickness and subchondral bone area. Associations 
between physical performance and cartilage thickness and bone area were largely mediated by 
lean mass and were independent of total physical activity. 
 
Our finding that lean mass was positively associated with cartilage thickness and bone area in 
the MFTC and LFTC is consistent with studies looking at lean mass and cartilage volume loss, 
where lean mass was associated with greater tibial cartilage volume cross-sectionally in young 
to middle-aged adults (ages 25-60 years) [80, 195] and over 5 years in young adults [81]. Lean 
mass was also associated with reduced cartilage volume loss over 2.9 years in older adults [79]. 
Additionally, loss of muscle mass was associated with greater cartilage volume loss over 2 
years [195]. Environmental factors could play important roles; for example, exercise may elicit 
the lean mass gains [207] and then provide greater stability in the knee joint, which is a 
protective mechanical factor for OA [208]. 
 
We did not identify any consistent associations between fat mass and cartilage thickness or 
subchondral bone area. This is similar to literature on cartilage volume, where no association 
between fat mass and cartilage volume loss was found in two studies of middle-aged to older 
adults [80, 195], but this is inconsistent with a third study looking exclusively at young adults 
[81]. While we looked at fat mass globally, adipose tissue in different locations may have 
different effects: subcutaneous, visceral and intramuscular adipose tissues may be detrimental 
to the knee joint, while local adipose tissues, for example, normal infrapatellar fat pad (without 
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signal intensity alteration on MRI), could have protective effects on knee OA, and the role of 
intermuscular adipose tissue in knee OA remains unclear [209]. 
 
We did not find associations between physical activity and cartilage thickness or bone area. 
This is not consistent with other reports, where physical activity was associated with tibial 
cartilage volume in young adults (total activity) [93] and healthy middle-aged women (sports 
participation) [210]. This may be due to the inability of our questionnaire to distinguish 
between weight-bearing and non-weight-bearing activities [64]; alternatively, this may suggest 
cartilage thickness and bone area in the whole joint are not responsive to physical activities in 
young adults. 
 
We found muscular strength (hand grip strength), power (long jump) and cardiorespiratory 
performance (PWC170) were positively associated with cartilage thickness and bone area. 
These were consistent with our previous study on tibial cartilage volume and bone area in 
young adults [93]. The significant associations largely disappeared after adjustment for lean 
mass, suggesting the effects of physical performance was mediated by lean mass; further 
mediation analysis confirmed this. Although lean mass explained most of the effects of hand 
grip strength and PWC170 on knee cartilage thickness, it only had moderate mediating effects 
on the association between long jump and cartilage thickness, suggesting other factors such as 
motor coordination may play roles in this association [211]. The association between leg 
strength and cartilage thickness was not significant, maybe due to leg strength being less 
strongly associated with lean muscle mass in the thigh compared with leg power [212]. 
 
Strengths of our study include that knee MRI was acquired in young adults (usually older adults 
are studied), cartilage thickness and subchondral bone area were studied rather than cartilage 
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volume and objective measures of physical performance were used. Some limitations of our 
study should be considered. First, we only had a modest sample size from one urban centre in 
Australia (as opposed to coverage of the whole Australia in the CDAH study), so the 
generalizability of study results may be limited. We compared characteristics between 
participants in the current study and in the remainder of CDAH study and the remainder of the 
CDAH Knee Cartilage Study. The current sample was comprised of younger and healthier 
participants. These differences have the potential to lead results towards the null, but not 
statistical significance, as healthier participants were less likely to report knee joint alterations 
[93, 192]. Second, we did not collect body composition, physical activity and physical 
performance measures during follow-up and MRI at baseline, so we were unable to describe 
longitudinal changes in exposure measures and knee cartilage and bone morphology. The 
changes in exposure measures and knee cartilage and bone morphology are important 
properties in knee OA research and are worthy of future studies. Third, body composition 
estimates based on skinfolds may not be as accurate as those based on dual-energy X-ray 
absorptiometry. Reassuringly, our measures have been validated [119, 213]. Fourth, physical 
activity measures, based on self-reported answers, were not objective. Reassuringly, previous 
studies have reported that the IPAQ-L has acceptable reliability and validity when assessing 
levels of physical activity among healthy adults (18–65 years) [214, 215]. Fifth, we did not 
have synovitis or cartilage composition measures, and the effects from these parameters should 
be identified in future studies. 
 
In conclusion, greater lean mass and better physical performance measured 4-5 years prior were 
associated with greater knee cartilage thickness and subchondral bone area in young adults, 
and the associations of physical performance were largely mediated by lean mass. These 
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Chapter 6: Association of glucose homeostasis and metabolic syndrome 
with knee cartilage defects and cartilage volume in young adults 
 
(Meng T et al. Seminars in Arthritis and Rheumatism. 2020 Apr; 50(2):192-197.) 
 
  




Knee osteoarthritis (OA) is a common joint disease worldwide, which causes severe knee pain, 
stiffness and dysfunction [164]. Currently, there are no proven therapies which can arrest or 
delay disease progression. Thus, identifying the risk factors of knee OA in early life could be 
important for disease prevention [141]. 
 
Magnetic resonance imaging (MRI) is a sensitive technique for examining early structural 
changes in knee joint [163], including imaging biomarkers of knee OA such as cartilage defects 
and loss of cartilage volume [34]. Cartilage defects and loss of cartilage volume have been 
associated with knee pain [37, 166] and subsequent knee replacement surgery [54, 137]  in 
observational studies, and were set as important endpoints in clinical trials [55, 216]. Therefore, 
preventing knee cartilage defects and loss of cartilage volume may be an effective way to 
prevent knee OA. 
 
Diabetes mellitus (DM) and OA coexist in the general population [217]. Experimental studies 
demonstrated that hyperglycaemia can decrease transport of dehydroascorbate into 
chondrocytes, which then compromises synthesis of type II collagen and leads to cartilage 
destruction [218]. Additionally, hyperglycaemia is associated with higher inflammatory 
responses in OA chondrocytes [219], which is detrimental to articular cartilage. A recent 
systematic review reported that there is limited evidence from epidemiological studies to 
support an independent association between DM and knee OA. However, the review stressed 
the requirement for prospective studies, which use objective and appropriate measures for both 
DM and OA and account for important confounding factors, such as age, sex and body mass 
index (BMI), to examine the independent associations [95]. 
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Metabolic syndrome (MetS), defined as central obesity, dyslipidaemia, impaired fasting 
glucose and hypertension, has recently attracted interest in knee OA research as MetS shares 
many causal pathways with knee OA [191]. Although previous narrative reviews summarised 
several potential pathophysiologic pathways between MetS and knee OA [220-222], a recent 
systematic review found insufficient data from epidemiological studies to confirm the links 
between MetS and knee OA [107]. The systematic review suggested the need for future studies, 
which account for weight or BMI and examine early stage of disease [107]. 
 
Therefore, using data from a cohort of young adults with knee structures measured by MRI, 
we aimed to describe the associations of glucose homeostasis and MetS measures with knee 
cartilage defects and cartilage volume. 
  





The Childhood Determinants of Adult Health (CDAH) Study was conducted on a nationwide 
sample of young adults in Australia. During 2004-2006, participants attended clinics which 
were located at sites in major cities and regional centres around Australia. Measures of 
anthropometrics, glucose homeostasis, metabolic syndrome and physical activity were 
collected during the clinic visit [114]. The CDAH Knee Cartilage Study was a subsequent sub-
study of the CDAH study where participants completed knee MRI scans during 2008-2010. 
 
We used the following strategy to recruit participants from the CDAH study. Participants 
residing in metropolitan Melbourne and Sydney were contacted by mail and were invited to 
participate in the CDAH Knee Cartilage Study. Participants who agreed to participate were 
assessed for eligibility. Exclusion criteria included being pregnant, having had diseases that 
might affect knee cartilage (including rheumatoid arthritis, ankylosing spondylitis, juvenile 
idiopathic arthritis and psoriatic arthritis), or having MRI contraindications. The remaining 
participants were asked to have an MRI scan at Epworth Hospital in Melbourne or North Shore 
Private Hospital in Sydney. 
 
This study was approved by the Southern Tasmania Health and Medical Human Research 
Ethics Committee (HREC), the Monash University HREC and the Northern Sydney and 
Central Coast Area Health HREC. All participants provided written informed consent. 
 
6.2.2 Anthropometric measurements 
Weight was measured to the nearest 0.1 kg (with shoes and bulky clothing removed) using 
Heine scales (Heine, Dover, NH). Height was measured to the nearest 0.1 cm (with shoes and 
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socks removed) using a stadiometer (Invicta, Leicester, UK). BMI was calculated as weight in 
kilograms divided by height in meters squared. 
 
6.2.3 Glucose homeostasis measurements 
Fasting glucose and insulin levels were measured using venous blood samples collected from 
the antecubital vein after a 12-hour fast. An Olympus AU5400 automated analyser (Olympus 
Optical, Tokyo, Japan) was used to enzymatically measure fasting glucose. A microparticle 
enzyme immunoassay kit (AxSYM; Abbot Laboratories, Abbot Park, IL) or an 
electrochemiluminescence immunoassay (Elecsys Modular Analytics E170; Roche 
Diagnostics, Mannheim, Switzerland) with inter-assay standardisation was used to measure 
fasting insulin. Glucose homeostasis measures, including homeostatic model assessment 2-
insulin resistance (HOMA2-IR), HOMA2-beta cell function (HOMA2-β) and HOMA2-insulin 
sensitivity (HOMA2-S), were calculated by a homeostasis model assessment calculator 
(version 2.2.3 available from http://www.dtu.ox.ac.uk/homacalculator) using fasting glucose 
and fasting insulin. 
 
6.2.4 MetS measurements 
MetS was defined using the harmonized definition [120]. Five components of MetS and their 
thresholds were proposed in the definition. MetS was diagnosed when at least three of the five 
components were present. The details of MetS definition and thresholds of MetS components 
have been published elsewhere [120]. We use the following methods to collect the MetS 
measures: Waist circumference was measured at the narrowest point between the lower costal 
border and the iliac crest to the nearest 0.1 cm using a constant tension tape; high waist 
circumference was defined as waist circumference ≥102 cm in males or ≥88 cm in females. 
Fasting glucose was measured as described above; hyperglycaemia was defined as fasting 
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glucose of ≥5.6 mmol/L. Triglyceride and high-density lipoprotein cholesterol (HDL-C) were 
measured enzymatically using an Olympus AU5400 automated analyser (Olympus Optical, 
Tokyo, Japan). Hypertriglyceridemia was defined as serum triglycerides ≥1.7 mmol/L, and 
low HDL-C was defined as HDL-C <1.03 mmol/L in males or <1.3 mmol/L in females. Resting 
systolic and diastolic blood pressure readings were recorded after 5 min of quiet sitting using 
an OMRON HEM907 Digital Automatic Blood Pressure Monitor (Omron Healthcare Co., Ltd., 
Kyoto, Japan), and the mean of three recordings was used. Hypertension was defined as blood 
pressure ≥ 130/85 mmHg. 
 
6.2.5 Physical activity measurements 
Physical activity was assessed using the long version of the International Physical Activity 
Questionnaire. Participants were asked to report the total time (minutes) and frequency 
(times/week) of occupational, commuting, domestic and leisure activity during the past week. 
Physical activities were calculated by multiplying frequency by duration to represent minutes 
per week of vigorous, moderate and walking activity. Time spent in each domain was summed 
to provide the estimate of total minutes of physical activity. 
 
6.2.6 MRI measurements 
MRI scans were obtained from 2 hospitals, which used the same type of machine (General 
Electric Medical Systems, Milwaukee, WI, USA). Knees were imaged on a 1.5 T whole-body 
magnetic resonance unit with use of a commercial transmit-receive extremity coil. The 
following image sequences were used: (1) a T1-weighted, fat-suppressed 3-dimensional (3D) 
spoiled gradient-recalled acquisition in the steady state; flip angle 55°; repetition time 58 msec; 
echo time 12 msec; field of view 16 cm; 60 partitions; 512×512-pixel matrix; acquisition time 
11 min, 56 s; 1 acquisition. Sagittal images were obtained at a partition thickness of 1.5 mm 
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and an in-plane resolution of 0.31×0.31 mm (512×512 pixels). (2) Proton density-weighted fat-
suppressed two-dimensional fast spin-echo coronal images at a partition thickness of 3.3 mm 
and an in-plane resolution of 0.31×0.31 mm (512×512 pixels); repetition time 3800 msec; echo 
time 45 msec. 
 
Knee cartilage defects were measured as previously reported [223] in an ordinal scale using 
the T1-weighted spoiled gradient-recalled sagittal MR images and proton density-weighted fast 
spin-echo coronal MR images together. Grade 0 indicated a normal cartilage. Grade 1 indicated 
focal blistering and low-signal intensity area in T1-weighted sagittal images or high-signal 
intensity area in proton density-weighted images with intact surface/bottom. Grade 2 indicated 
a loss of thickness of <50% on surface/bottom of the cartilage. Grade 3 represented a loss of 
thickness >50%. Grade 4 indicated a full-thickness chondral wear with exposure of 
subchondral bone. A prevalent cartilage defect was defined as a cartilage defect score of ≥2 
at any site within that compartment. Intraobserver reliability expressed as an intraclass 
correlation coefficient ranged from 0.89 to 0.94. 
 
Cartilage volume was determined by means of 3D image processing on an independent work 
station using software program OsiriX (Geneva, Switzerland). Individual plates were isolated 
by manually drawing disarticulation contours around the cartilage boundaries on a section-by-
section basis. These data were then re-sampled by means of bilinear and cubic interpolation 
(area of 312×312 μm2 and thickness of 1.5 mm, continuous sections) for the final 3D rendering. 
The coefficients of variation for cartilage volume measures were 2.1-2.6%. Femoral cartilage 
volume was not measured, as it strongly correlates with tibial cartilage volume [125]. 
 
6.2.7 Statistical analyses 
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Histograms and Q-Q plots were used to assess the normality of continuous variables. Mean 
(standard deviation), median (interquartile range), and number (percentage) were used to 
describe normally-distributed variables, skewed variables and categorical variables, 
respectively. T-tests, Wilcoxon rank-sum test and Chi-square tests were used to assess 
differences in normally-distributed variables, skewed variables and categorical variables 
between groups, respectively. Univariable and multivariable log binomial regression models 
were used to estimate relative risk (RR) for associations of glucose homeostasis and MetS 
measures with knee cartilage defects before and after adjustment for potential confounders. 
Univariable and multivariable linear regression models were used to estimate β coefficients for 
associations of glucose homeostasis and MetS measures with knee cartilage volume before and 
after adjustment for potential confounders. Age, sex, BMI (except when high waist 
circumference was the predictor) and total physical activity were included as potential 
confounders based on biological plausibility. A p-value less than 0.05 (2-tailed) was considered 
statistically significant. All statistical analyses were performed in Stata (Texas, USA), version 
15.0. 
  




6.3.1 Characteristics of the participants 
A total of 2410 participants completed clinic visit during the CDAH Study and 330 participants 
completed MRI scans during the CDAH Knee Cartilage Study. The follow-up time was 4-5 
years. Nonparticipation in the CDAH Knee Cartilage Study was related to the following: not 
residing in Melbourne or Sydney (n=1646), not responding or refusing (n=235), pregnant (n=8), 
rheumatoid arthritis (n=2), MRI contraindication (n=13), withdrawal (n=68), long distance for 
traveling to the imaging site (n=103), work/family commitments (n=3), moving interstate (n=2). 
In the current study, 322 participants were included in analyses for cartilage defects and 328 
for cartilage volume, as 8 scans were unreadable for cartilage defects and 2 for cartilage volume. 
 
Participants were aged 31-41 (mean 35.4) years when MRI was acquired, 155 (47%) were 
female. 40 (12.7%) participants had hyperglycaemia and 21 (6.7%) had MetS. Participants 
included in the current study did less physical activity and had higher fasting glucose and lower 
HOMA2-β than those in the remainder of the CDAH Study, whereas other characteristics were 
comparable (Table 6.1). 
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Table 6.1 Characteristics of the participants in Chapter 6 and the remainder of CDAH study 
 MRI measures P value 
 Yes (n=328) No (n=2002)  
Age a (years) 30.8 (2.7) 31.1 (2.6) 0.138 
Female, n (%) 155 (47.3) 1037 (51.5) 0.150 
BMI (kg/m2) 25.3 (4.1) 25.8 (4.9) 0.090 
Total physical activity (hour/week), 
median (IQR) 
9.6 (5.6, 15.7) 11.1 (6.3, 17.9) 0.017 
Glucose homeostasis measures, 
median (IQR) 
   
  Fasting glucose (mmol/L) 5.1 (4.8, 5.3) 5.0 (4.7, 5.3) 0.017 
  Fasting insulin (mU/L) 5.8 (4.2, 7.9) 6.0 (4.3, 8.7) 0.207 
  HOMA2-IR (unit) 0.80 (0.60, 1.10) 0.80 (0.60, 1.20) 0.146 
  HOMA2-β (unit) 0.79 (0.66, 1.00) 0.85 (0.68, 1.06) 0.005 
  HOMA2-S (unit) 1.27 (0.95, 1.69) 1.23 (0.86, 1.67) 0.168 
MetS measures, n (%)    
  MetS  21 (6.7) 136 (7.2) 0.744 
  High waist circumference b 36 (11.3) 293 (14.6) 0.121 
  Hyperglycaemia c 40 (12.7) 195 (10.3) 0.192 
  Hypertriglyceridemia d 49 (15.6) 280 (14.8) 0.716 
  Low HDL-C e 52 (16.5) 371 (19.6) 0.201 
  Hypertension f 60 (18.4) 436 (21.7) 0.169 
Cartilage defects, n (%)    
  Patellar 78 (24.2)   
  Tibiofemoral  47 (14.6)   
Cartilage volume (mm3)    
  Patellar 2939 (752)   
  Tibial 3896 (1005)   
 
Values are mean (standard deviation) unless otherwise stated. 
MRI, magnetic resonance imaging; BMI, body mass index; CDAH, Childhood Determinants 
of Adult Health Study HOMA2-IR, homeostatic model assessment 2-insulin resistance; 
HOMA2-β, homeostatic model assessment 2-beta cell function; HOMA2-S, homeostatic 
model assessment 2-insulin sensitivity; HDL-C, high-density lipoprotein cholesterol; IQR, 
interquartile range; MetS, metabolic syndrome.  
aAge in the CDAH study. 
bDefined as waist circumference ≥102 cm in males or ≥88 cm in females.   
cDefined as fasting glucose ≥5.6 mmol/L.   
dDefined as serum triglycerides ≥1.7 mmol/L.   
eDefined as HDL-C <1.03 mmol/L in males or <1.3 mmol/L in females.   
fDefined as blood pressure ≥130/85 mm Hg.  
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6.3.2 Glucose homeostasis and knee cartilage defects 
Higher fasting insulin, HOMA2-IR and HOMA2-β were significantly associated with higher 
risk of tibiofemoral cartilage defects and higher HOMA2-S was associated with lower risk of 
tibiofemoral cartilage defects before and after adjustment for age, sex, BMI and physical 
activity (Table 6.2). Fasting glucose was not associated with tibiofemoral cartilage defects. 
Glucose homeostasis measures, including fasting glucose, fasting insulin, HOMA2-IR, 
HOMA2-β and HOMA2-S, were not associated with patellar cartilage defects in either 
univariable or multivariable analyses (Table 6.2). 
  








RR (95% CI) RR (95% CI) 
Patellar 
  
  Fasting glucose, mmol/L 0.62 (0.37 to 1.03) 0.55 (0.29 to 1.04) 
  Fasting insulin, mU/L 0.99 (0.94 to 1.04) 0.95 (0.88 to 1.02) 
  HOMA2-IR, per unit 0.90 (0.61 to 1.33) 0.60 (0.32 to 1.14) 
  HOMA2-β, per unit 1.10 (0.61 to 1.96) 0.87 (0.38 to 1.99) 
  HOMA2-S, per unit 1.01 (0.70 to 1.45) 1.15 (0.76 to 1.75) 
Tibiofemoral 
  
  Fasting glucose, mmol/L 1.31 (0.72 to 2.40) 0.89 (0.41 to 1.93) 
  Fasting insulin, mU/L 1.05 (1.02 to 1.07) 1.05 (1.01 to 1.08) 
  HOMA2-IR, per unit 1.42 (1.15 to 1.76) 1.44 (1.08 to 1.92) 
  HOMA2-β, per unit 2.13 (1.24 to 3.65) 2.59 (1.33 to 5.07) 
  HOMA2-S, per unit 0.46 (0.27 to 0.78) 0.36 (0.18 to 0.72) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for age, sex, body mass index and physical activity. 
CI, confidence interval; HOMA2-IR, homeostatic model assessment 2-insulin resistance; 
HOMA2-β, homeostatic model assessment 2-beta cell function; HOMA2-S, homeostatic 
model assessment 2-insulin sensitivity; RR, relative risk. 
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6.3.3 Glucose homeostasis and knee cartilage volume 
Glucose homeostasis measures were not significantly associated with cartilage volume in 
univariable analyses, except for the positive associations between fasting glucose and cartilage 
volume in patella and tibia, and the negative association between HOMA2-β and tibial cartilage 
volume (Table 6.3). Associations were no longer significant after adjustment for age, sex, BMI 
and physical activity (Table 6.3). 
 
  









β (95% CI) β (95% CI) 
Patellar 
  
  Fasting glucose, mmol/L 255.2 (60.6 to 449.7) -92.9 (-293.3 to 107.4) 
  Fasting insulin, mU/L -2.6 (-21.3 to 16.1) -6.3 (-25.1 to 12.4) 
  HOMA2-IR, per unit 1.1 (-154.6 to 156.9) -40.6 (-195.9 to 114.7) 
  HOMA2-β, per unit -228.8 (-513.6 to 56.0) -48.0 (-330.5 to 234.5) 
  HOMA2-S, per unit 9.5 (-151.9 to 171.0) 32.4 (-125.6 to 190.4) 
Tibial 
  
  Fasting glucose, mmol/L 561.2 (307.6 to 814.8) -22.0 (-280.0 to 236.1) 
  Fasting insulin, mU/L -4.9 (-29.7 to 19.9) -17.5 (-41.5 to 6.6) 
  HOMA2-IR, per unit -15.3 (-221.5 to 190.8) -127.8 (-323.1 to 67.6) 
  HOMA2-β, per unit -463.2 (-838.1 to -88.4) -236.8 (-592.0 to 118.4) 
  HOMA2-S, per unit 19.8 (-193.9 to 233.6) 64.9 (-134.3 to 264.1) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for age, sex, body mass index and physical activity. 
CI, confidence interval; HOMA2-IR, homeostatic model assessment 2-insulin resistance; 
HOMA2-β, homeostatic model assessment 2-beta cell function; HOMA2-S, homeostatic 
model assessment 2-insulin sensitivity.  
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6.3.4 MetS and knee cartilage defects 
MetS and its components were not associated with patellar cartilage defects in univariable 
analyses, except hypertriglyceridemia was associated with higher risk of patellar cartilage 
defects (Table 6.4); however, this association was no longer statistically significant after 
adjustment for age, sex, BMI and physical activity (Table 6.4). MetS and its components were 
not associated with tibiofemoral cartilage defects in univariable analyses, except for the 
association between low HDL-C and higher risk of tibiofemoral cartilage defects (Table 6.4). 
The significant association persisted and the association between high waist circumference and 
higher risk of tibiofemoral cartilage defects became significant after adjustment for 
confounders (Table 6.4). 
  








RR (95% CI) RR (95% CI) 
Patellar 
  
  MetS 1.37 (0.72 to 2.60) 1.38 (0.60 to 3.21) 
  High waist circumference b 1.44 (0.86 to 2.39) 1.13 (0.59 to 2.15) 
  Hyperglycaemia c 0.91 (0.50 to 1.68) 0.76 (0.32 to 1.78) 
  Hypertriglyceridemia d 1.66 (1.08 to 2.55) 1.66 (0.97 to 2.84) 
  Low HDL-C e 0.93 (0.55 to 1.60) 0.88 (0.48 to 1.61) 
  Hypertension f 1.15 (0.72 to 1.84) 1.23 (0.70 to 2.17) 
Tibiofemoral 
  
  MetS 2.06 (0.99 to 4.29) 1.39 (0.58 to 3.32) 
  High waist circumference b 1.86 (0.98 to 3.54) 2.32 (1.18 to 4.54) 
  Hyperglycaemia c 1.24 (0.60 to 2.57) 0.90 (0.37 to 2.14) 
  Hypertriglyceridemia d 1.32 (0.68 to 2.56) 0.89 (0.40 to 1.96) 
  Low HDL-C e 2.45 (1.43 to 4.19) 1.99 (1.08 to 3.69) 
  Hypertension f 1.57 (0.86 to 2.84) 1.50 (0.77 to 2.95) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for age, sex, body mass index (except when high waist circumference was the 
predictor) and physical activity. 
bDefined as waist circumference ≥102 cm in males or ≥88 cm in females.   
cDefined as fasting glucose ≥5.6 mmol/L.   
dDefined as serum triglycerides ≥1.7 mmol/L.   
eDefined as HDL-C <1.03 mmol/L in males or <1.3 mmol/L in females.   
fDefined as blood pressure ≥130/85 mmHg.   
CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic 
syndrome; RR, relative risk. 
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6.3.5 MetS and knee cartilage volume 
MetS and its components were not significantly associated with cartilage volume in univariable 
analyses, except for the positive associations of hyperglycaemia and hypertension with tibial 
cartilage volume (Table 6.5). After adjustment for age, sex, BMI and physical activity, the 
significant associations disappeared (Table 6.5). 
  









β (95% CI) β (95% CI) 
Patellar 
  
  MetS 131.1 (-205.0 to 467.3) -116.2 (-432.4 to 199.9) 
  High waist circumference b -82.7 (-345.9 to 180.4) 20.1 (-213.0 to 253.2) 
  Hyperglycaemia c 212.8 (-37.3 to 462.9) -64.1 (-306.5 to 178.2) 
  Hypertriglyceridemia d 119.7 (-111.5 to 350.9) -52.0 (-170.9 to 275.0) 
  Low HDL-C e -33.1 (-259.2 to 192.9) -20.5 (-221.7 to 180.8) 
  Hypertension f 90.2 (-121.1 to 301.5) -188.7 (-380.4 to 3.1) 
Tibial 
  
  MetS 210.1 (-234.8 to 655.1) -255.7 (-660.2 to 148.8) 
  High waist circumference b -218.2 (-566.4 to 130.0) -120.7 (-418.9 to 177.4) 
  Hyperglycaemia c 438.5 (108.4 to 768.6) -55.8 (-367.5 to 255.9) 
  Hypertriglyceridemia d 165.9 (-140.2 to 472.0) -154.0 (-439.3 to 131.4) 
  Low HDL-C e 2.4 (-297.0 to 301.8) -109.2 (-366.9 to 148.6) 
  Hypertension f 333.7 (53.6 to 613.7) -38.4 (-285.4 to 208.6) 
 
Bold denotes statistical significance, p<0.05. 
aAdjusted for age, sex, body mass index (except when high waist circumference was the 
predictor) and physical activity. 
bDefined as waist circumference ≥102 cm in males or ≥88 cm in females.   
cDefined as fasting glucose ≥5.6 mmol/L.   
dDefined as serum triglycerides ≥1.7 mmol/L.   
eDefined as HDL-C <1.03 mmol/L in males or <1.3 mmol/L in females.   
fDefined as blood pressure ≥130/85 mmHg.   
CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic 
syndrome; RR, relative risk. 
  




This is the first study describing associations of glucose homeostasis and MetS measures with 
knee cartilage defects and cartilage volume in young adults. Our major findings were that 
higher levels of fasting insulin, HOMA2-IR and HOMA2-β were associated with an increased 
risk of tibiofemoral cartilage defects, and higher level of HOMA2-S was associated with a 
decreased risk of tibiofemoral cartilage defects. In addition, high waist circumference and low 
HDL-C were associated with higher risk of tibiofemoral cartilage defects. 
 
Most previous studies describing the association between serum glucose and knee OA have 
focused on the incidence of radiographic OA (according to Kellgren-Lawrence grade) [95], 
except for two studies setting T2-relaxation time [111] or cartilage volume [224] as the 
outcome by using MRI. In one study, self-reported DM was associated with higher baseline T2 
(more severe cartilage degradation), but not progression of T2 over 2 years [111]. In the other 
study, serum glucose (measured 10-14 years prior to baseline MRI) was associated with higher 
annual loss of tibial cartilage volume over 2 years in females but not in males [224]. Both 
studies used inaccurate glucose measures (self-reported or measured a long time ago) and did 
not measure serum insulin. In addition, the populations of interest in these studies were middle-
aged or older-aged (40-69 years), whereas no studies were conducted in young adults. 
 
In our study, we used both fasting glucose and fasting insulin, and calculated measures of 
insulin resistance, beta cell function and insulin sensitivity using the HOMA2 calculator, which 
is an effective tool to assess glucose homeostasis in clinical and epidemiological studies [225]. 
We collected MRI-based cartilage measures from young adults, which can predict knee OA 
and even joint replacement surgery in later life. Our findings that worse glucose homeostasis 
measures (except for fasting glucose) were associated with higher risk of tibiofemoral cartilage 
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defects suggested the detrimental effects of insulin resistance on knee cartilage. The lack of 
association for fasting glucose may be due to the age of our cohort. Young adults may have 
increased insulin secretion and insulin resistance, whereas their fasting glucose levels could 
still be in healthy range [226]. Furthermore, we only found significant associations in the 
tibiofemoral compartment, but not in the patella. The underlying reason was unclear, but may 
reflect the fact that pathological mechanisms involved in patellofemoral OA and tibiofemoral 
OA are different [227]. We did not find consistent associations between glucose homeostasis 
measures and knee cartilage volume; this may be due to knee cartilage defects occurring prior 
to cartilage volume loss in early knee OA [121]. 
 
Previous studies did not find independent associations between MetS and radiographic knee 
OA cross-sectionally [228] or longitudinally [229]. There is only one study that used an MRI-
based outcome (compositional MRI outcome but not structural MRI outcome), which reported 
participants with ≥3 metabolic components (versus <3) had higher baseline T2-relaxation time 
(more severe cartilage degradation) [111]. However, the study used self-reported DM and fat 
consumption (calculated from food questionnaire) to represent impaired glucose tolerance and 
dyslipidaemia; in addition, though the study selected the younger half of the source cohort, the 
participants were middle-aged or older-aged (45-60 years). 
 
Our study addressed the issues in the previous study by using MRI-based structural outcomes 
in young adults and objective measures of MetS components. We found high waist 
circumference and low HDL-C were associated with higher risk of tibiofemoral cartilage 
defects. These results are consistent with previous studies, where central obesity was associated 
with thinner cartilage thickness in young adults [230] and reduced HDL was associated with 
knee OA in mice models [231]. We did not find associations between MetS and cartilage 
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defects or cartilage volume. The reason may be that our participants were young adults (31-41 
years) and the prevalence of MetS was low (6.7%). We speculate that MetS will be associated 
with knee OA when the prevalence of MetS increases with ageing, though this needs to be 
confirmed by future studies. 
 
Strengths of our study include the selection of a population-based sample of young adults and 
the use of knee MRI-based structural measures of cartilage. We also used objective measures 
of glucose homeostasis and MetS. Some limitations of our study should be considered. First, 
we only had a modest sample size from two urban centres in Australia (as opposed to the 
coverage of all Australian states/territories in CDAH study), so the generalizability of study 
results may be limited. We compared characteristics between participants in current study and 
in the remainder of CDAH Study: the current sample did less physical activity and had higher 
fasting glucose and lower HOMA2-β. The effects of these differences on our results were 
unknown though the differences were relatively small. Second, we did not acquire baseline 
MRI, so we were unable to describe longitudinal changes in knee cartilage defects and cartilage 
volume. Third, we did not collect knee alignment data, so we were unable to assess its potential 
effects on our findings. 
 
In conclusion, insulin resistance, high waist circumference and low HDL-C were associated 
with higher risk of tibiofemoral cartilage defects, suggesting glucose homeostasis and some 














Chapter 7: Summary and future directions 
  




Given the heavy disease burden of knee osteoarthritis (OA) and the lack of effective therapies, 
the prevention of knee OA is critically important. Although knee OA mostly affects middle-
aged or older adults, young adults are the ideal target population in knee OA prevention. 
Several potential risk factors and protective factors of knee joint health in young adults were 
explored in this thesis. 
 
In Chapter 3, we described the associations between adiposity measures in childhood and knee 
cartilage defects and bone marrow lesions (BMLs) in adulthood. We found that childhood 
adiposity measures, including body weight, body mass index (BMI), overweight status and fat 
mass, were associated with the increased risk of patellar cartilage defects 25 years later. We 
also found childhood overweight status was associated with the increased risk of patellar BMLs 
25 years later. These results existed after adjusting for adult adiposity measures, suggesting 
these associations were independent. The long-term detrimental effects of childhood adiposity 
on adult patella addressed the importance of knee OA prevention on an early stage. 
 
In Chapter 4, we described the associations between adiposity measures in childhood and 
adulthood and knee cartilage thickness, volume and bone area in young adults. We found 
childhood body weight and BMI were negatively associated with adult patellar bone area. Bone 
accrual during early life is a physiologic process, as it could distribute loads on a larger surface. 
Thus, this finding suggests the long-term detrimental effects of childhood adiposity on patellar 
bone morphology. We found adult weight was positively associated with bone area in both 
medial and lateral femorotibial compartments, indicating the natural response of weight-
bearing joint to additional mechanical stress. We found that adult waist-hip ratio (WHR) was 
negatively associated with cartilage thickness, cartilage volume and bone area measured 4-5 
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years later; these results indicated the detrimental effects of central obesity on knee cartilage 
and bone morphology in young adults. Moreover, the z-score change of WHR from childhood 
to adulthood was negatively associated with knee cartilage thickness, cartilage volume and 
bone area, suggesting the track of central obesity during early life could affect knee structures 
in young adults. 
 
In Chapter 5, we described associations of body composition, physical activity and physical 
performance with knee cartilage thickness and subchondral bone area in young adults. We 
found lean mass was positively associated with cartilage thickness and bone area, suggesting 
the protective effects of lean mass on knee structures. We did not find associations between 
physical activity and cartilage thickness or bone area. We found most physical performance 
measures were positively associated with knee cartilage thickness and bone area. However, the 
associations of physical performance were largely disappeared after further adjusting for lean 
mass, suggesting lean mass may be an important mediator, and the results from mediation 
analyses confirmed the mediation effects of lean mass. Thus, higher lean mass may be 
beneficial to maintain knee joint health in young adults. 
 
In Chapter 6, we described the associations of glucose homeostasis and metabolic syndrome 
(MetS) measures with knee cartilage defects and cartilage volume in young adults. We found 
insulin resistance other than fasting glucose was associated with the higher risk of tibiofemoral 
cartilage defects. Moreover, some MetS components (high waist circumference and low high-
density lipoprotein cholesterol (HDL-C)), but not MetS, were associated with the higher risk 
of tibiofemoral cartilage defects. The lack of association of fasting glucose or MetS may be 
due to the young age of our cohort: The prevalence of hyperglycaemia and MetS were low so 
we had little power to find significant results. We did not find associations about cartilage 
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volume; this may be due to knee cartilage defects occurring prior to cartilage volume loss in 
early knee OA. Nonetheless, our findings suggested that metabolic factors may involve in early 
cartilage damage in young adults. 
 
In summary, the findings from this thesis indicate that early life factors may affect knee joint 
health in young adults. Our findings may be useful in developing preventive strategies for knee 
OA. However, our findings need to be confirmed and extended in future studies. The potential 
future directions are suggested in the following section.  
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7.2 Future directions 
7.2.1 Further follow-up 
Our findings provided important and novel information for maintaining knee joint health and 
preventing knee OA during early life. However, our studies were limited by the magnetic 
resonance imaging (MRI) scans as they were only collected once. The longitudinal changes of 
knee structures are important in knee OA research. Some knee structural abnormalities, 
including cartilage defects and BMLs, can be reversible [157, 232]. Reversing these 
abnormalities may relieve the knee symptoms and slow down the structural progression of knee 
OA. Moreover, knee cartilage loss is the hallmark of knee OA. Knee cartilage loss rather than 
cartilage volume per se has been predictive of total knee replacement [53]. Furthermore, the 
expansion of tibial bone area in adulthood can lead to the development of cartilage defects and 
predict the following cartilage loss and joint replacement [130]. Thus, the effects of early life 
factors on these structural changes are worthy of exploring in future studies. 
 
Further follow-up will also provide the unique opportunity to observe the transition from 
healthy knees to osteoarthritic knees. Evidence suggested that knee cartilage loss became 
evident at about 40 years old [233]. Similarly, the prevalence of knee cartilage defects and 
BMLs were higher in middle-aged adults than those in young adults [233]. Our participants are 
now aged 43-53 years, so the osteoarthritic characteristics in their knee joints are becoming 
evident. Further follow-up will enable us to describe the nature of knee OA onset and identify 
the long-term effects of early life factors on knee osteoarthritic changes in middle-aged adults. 
 
7.2.2 Large cohort studies 
The participants in our studies were residing in Sydney and Melbourne, as opposed to coverage 
of the whole Australia in the original cohort. Although we compared the characteristics of our 
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participants and the remainder in the original cohort and the slight differences may not bias our 
results, the generalizability of our findings still needs to be evaluated carefully. Moreover, the 
original cohort mainly targeted cardiovascular disease and type 2 diabetes, and we can only 
conduct the secondary analyses using the data in the main study. In childhood, we did not 
collect the data about knee joint health, for example, the knee injury history (though we asked 
the participants to recall that in adulthood), which may affect our results. Therefore, our 
findings need to be confirmed in future studies. Ideally, the large prospective studies, which 
have the representative sample of the whole population and mainly focus on knee joint health, 
should be conducted. 
 
7.2.3 Intervention studies 
The findings of this thesis suggested several potential interventions for knee OA prevention. 
The well-designed randomized controlled trials (RCTs) may confirm our findings and provide 
strong empirical evidence of the interventions’ efficacy on knee OA prevention. 
 
Weight management in childhood 
We reported childhood adiposity was associated with adult patellar abnormalities (cartilage 
defects and BMLs) in Chapter 3 and childhood adiposity was detrimental to adult patellar bone 
morphology (bone area) in Chapter 4, suggesting the long-term effects of childhood adiposity 
on patella. In 2017-18, about 25% (1.2 million) Australian children and adolescents (aged 2-
17 years) were overweight or obese [234], so the effective management in 
preventing/ameliorating excess weight gain in childhood may have significant effects in 
keeping patellar health. Several RCTs have been conducted to develop the intervention 
strategies for childhood obesity. A meta-analysis included 85 RCTs, which aimed the primary 
prevention of childhood obesity and related hypertension, and reported that the combination of 
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parental involvement, physical activity, health education, and eating habits could be effective 
in reducing children's BMI and blood pressure [235]. Moreover, a recent systematic review, 
which summarised the school-based weight management interventions targeting children aged 
4-12 years, concluded that increasing physical activity and reducing sedentary behaviour were 
the most effective interventions, and healthy diet and involving pupils’ parents and family 
could enhance the effectiveness [236]. 
 
Preventing/reducing central obesity and increasing lean mass in young adults 
We reported adult WHR and increasing WHR z-score from childhood to adulthood were 
negatively associated with cartilage thickness, volume and bone are in Chapter 4, and adult 
high waist circumference (≥102 cm in males or ≥88 cm in females) was associated with the 
higher risk of tibiofemoral cartilage defects in Chapter 6, suggesting the detrimental effects 
from central obesity. Given the prevalence of high waist circumference was 41% (8.1 million) 
among Australian adults in 2017-18 [234], preventing/reducing central obesity could be 
critically important. Though current approaches for obesity management largely focus on 
general obesity (defined by BMI) [237], they may be also effective in central obesity. Apart 
from pharmacotherapy and bariatric surgery which should be considered carefully because of 
their safety and cost-effectiveness, the lifestyle interventions (diet and exercise) remain the 
foundation of obesity management [237]. Reducing 15-30% energy intake from habitual intake 
may be sufficient and appropriate to decrease waist circumference [238]. Aerobic exercise may 
also be effective as it will notably enhance the energy expenditure [239]. However, the kinds 
of aerobic exercise should be selected carefully, as they should avoid causing knee injury or 
increasing the joint loading. 
 
Chapter 7: Summary and future directions 
138 
 
In Chapter 5, we reported that lean mass may be protective to knee cartilage and bone 
morphology. Thus, resistance training, which can increase lean mass, may also be helpful in 
knee OA prevention [240]. A combination program of diet, aerobic exercise and resistance 
training, which can reduce waist circumference and increase lean mass, may be reasonable. 
Previously, an RCT investigated the effects of diet and exercise on knee mechanistic loading 
and symptoms among older knee OA patients [241]. The results suggested that diet combined 
with aerobic and strength training could remarkably reduce knee compressive forces and 
improve knee symptoms in the participants over 18 months However, no similar studies have 
been done in young adults. Thus, further studies are needed to determine the optimal 
prescription of the combination program and explore its effects on knee OA prevention. 
 
Relieving insulin resistance and dyslipidaemia in young adults 
We reported that insulin resistance was associated with the higher risk of tibiofemoral cartilage 
defects in Chapter 6. This is consistent with a recent research hotspot, where metformin may 
be effective in treating knee OA. Metformin is an oral medication used in the treatment of type 
2 diabetes. Basic research has reported that metformin can limit the development and 
progression of knee OA in mice models through activating AMP-activated protein kinase 
signalling [242]. This finding may also apply to humans, as a prospective study reported that 
metformin use could reduce the cartilage volume loss over 4 years among knee OA patients 
with obesity [243]. However, no RCTs have confirmed whether metformin would protect knee 
cartilage and be a disease-modifying drug for obese knee OA patients. Our finding suggested 
the potential effects of metformin on knee OA prevention, as it may lower insulin resistance 
and prevent early cartilage damage. Future RCTs are needed to confirm our hypothesis. 
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We also reported that low HDL-C was associated with the higher risk of tibiofemoral cartilage 
defects in Chapter 6. Dyslipidaemia may affect knee cartilage through the shared 
pathophysiologic pathways between cardiovascular disease and knee OA [191]. Several studies 
explored the effects of lipid-lowing drugs on knee OA. A longitudinal study reported that using 
statins for >5 years was associated with the lower risk of developing knee pain over the 
following 4 years [244]. However, statin use did not reduce the risk of subsequent knee joint 
replacement in other cohorts [245, 246]. All the previous studies were observational studies 
and were conducted among older adults or knee OA patients. The effects of stains intervention 
in knee OA prevention among young adults are unclear. 
 
7.2.4 Other MRI measures 
In addition to the MRI measures used in this thesis, some other imaging biomarkers for early 
knee OA or novel MRI measures may be useful in knee OA prevention. Among these, we 
highlight compositional MRI, MRI-detected early osteophytes (MRI-OPs), and proximal 
tibiofibular joint (PTFJ) in this section. 
 
Compositional MRI 
The compositional MRI (T1ρ and T2 relaxation time) is able to detect early biochemical 
changes of knee cartilage prior to the morphologic changes [247]. T1ρ describes the spin-lattice 
relaxation in the rotating frame, higher T1ρ indicates the loss of proteoglycan in cartilage. T2 
reflects the ability of free water protons to move and to exchange energy inside the cartilage 
matrix, higher T2 indicates the damage of collagen and increase of water content in cartilage. 
Thus, higher T1ρ and T2 are important indicators of early cartilage degeneration. A recent 
meta-analysis reported that healthy people with higher T1ρ and T2 relaxation time were under 
higher risk of subsequent knee OA [248]. Using our unique longitudinal data to identify the 
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Osteophyte is a typical osteoarthritic structure and traditionally detected by radiograph. 
However, a cohort of Australian older adults (aged 50-80 years) reported that 85% of 
participants had MRI-detected osteophytes while only 10% of participants had 
radiographically-detected osteophytes [249]. The researchers later named the osteophytes, 
which can only be detected by MRI but not by radiograph, as MRI-OPs [250]. The MRI-OPs 
were dynamic in older adults from that cohort, with 46% worsened, 53% stable and 1% 
decreased over 2.6 years [251]. In the same setting, baseline MRI-OPs were associated with 
the higher risk of cartilage defects and BMLs in a site-specific manner and were suggested as 
an indicator of early-stage osteoarthritic progression [250]. However, neither the prevalence 
nor the natural history of MRI-OPs was described in young adults. The role of MRI-OPs in 
knee OA prevention during early life needs further exploration. 
 
PTFJ 
PTFJ is the joint located between lateral tibial condyle and fibular head. Recently, a novel 
method for measuring the morphological parameters of PTFJ using MRI have been developed 
and validated among older adults [252]. The parameters of the measure system include the 
contacting area on the PTFJ surface plane (S), the projection of S onto the horizontal plane (Sτ), 
the projection of S onto the sagittal plane (Sφ), and the projection of S onto the coronal plane 
(Sυ). The different parameters represent different mechanical loadings: S bears total force of 
the fibula from the tibia, Sτ carries load-bearing force to the fibula from the tibia in an upward 
direction, Sφ bears lateral stress-bolstering force of fibula from tibia in the inward direction, 
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and Sυ bears posterior stress-bolstering force of fibula from tibia in the forward direction. A 
nested matched case-control study has reported that S, Sτ and Sυ were associated with the 
higher risk of incident radiographic knee OA among older adults (average aged 60 years), 
suggesting their predictive value of knee OA [253]. However, no research identified the role 
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